CA2425473A1 - A composition and method for preparing amino acid chelates free of interfering ions - Google Patents
A composition and method for preparing amino acid chelates free of interfering ions Download PDFInfo
- Publication number
- CA2425473A1 CA2425473A1 CA002425473A CA2425473A CA2425473A1 CA 2425473 A1 CA2425473 A1 CA 2425473A1 CA 002425473 A CA002425473 A CA 002425473A CA 2425473 A CA2425473 A CA 2425473A CA 2425473 A1 CA2425473 A1 CA 2425473A1
- Authority
- CA
- Canada
- Prior art keywords
- amino acid
- metal
- ligand
- chelate
- molar ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 189
- 238000000034 method Methods 0.000 title claims abstract description 46
- 150000002500 ions Chemical class 0.000 title claims abstract description 43
- 230000002452 interceptive effect Effects 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title abstract description 21
- 229910052751 metal Inorganic materials 0.000 claims abstract description 162
- 239000002184 metal Substances 0.000 claims abstract description 162
- 239000013522 chelant Substances 0.000 claims abstract description 136
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 101
- 239000003446 ligand Substances 0.000 claims abstract description 84
- 239000000243 solution Substances 0.000 claims abstract description 76
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims abstract description 62
- 239000000292 calcium oxide Substances 0.000 claims abstract description 54
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims abstract description 29
- 239000000920 calcium hydroxide Substances 0.000 claims abstract description 20
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims abstract description 20
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims abstract description 20
- 230000007935 neutral effect Effects 0.000 claims abstract description 18
- 239000007864 aqueous solution Substances 0.000 claims abstract description 11
- 229940024606 amino acid Drugs 0.000 claims description 210
- 235000001014 amino acid Nutrition 0.000 claims description 206
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 105
- 239000004471 Glycine Substances 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 238000006243 chemical reaction Methods 0.000 claims description 47
- 239000010949 copper Substances 0.000 claims description 33
- 229910052802 copper Inorganic materials 0.000 claims description 32
- 239000011701 zinc Substances 0.000 claims description 28
- 229910052725 zinc Inorganic materials 0.000 claims description 28
- 239000011651 chromium Substances 0.000 claims description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 20
- 229910021645 metal ion Inorganic materials 0.000 claims description 20
- 239000011572 manganese Substances 0.000 claims description 19
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 18
- 229910052742 iron Inorganic materials 0.000 claims description 18
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 17
- 229910052804 chromium Inorganic materials 0.000 claims description 15
- 239000011777 magnesium Substances 0.000 claims description 15
- 229910052749 magnesium Inorganic materials 0.000 claims description 14
- 229910052748 manganese Inorganic materials 0.000 claims description 14
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 13
- 239000000376 reactant Substances 0.000 claims description 12
- 229910052925 anhydrite Inorganic materials 0.000 claims description 11
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 10
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 9
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 9
- 235000011116 calcium hydroxide Nutrition 0.000 claims description 9
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 9
- 150000001450 anions Chemical class 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 150000001768 cations Chemical class 0.000 claims description 6
- VVYPIVJZLVJPGU-UHFFFAOYSA-L copper;2-aminoacetate Chemical compound [Cu+2].NCC([O-])=O.NCC([O-])=O VVYPIVJZLVJPGU-UHFFFAOYSA-L 0.000 claims description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 6
- 108010016626 Dipeptides Proteins 0.000 claims description 5
- 229910015853 MSO4 Inorganic materials 0.000 claims description 5
- JNMKPXXKHWQWFB-UHFFFAOYSA-L 2-aminoacetate;manganese(2+) Chemical compound [Mn+2].NCC([O-])=O.NCC([O-])=O JNMKPXXKHWQWFB-UHFFFAOYSA-L 0.000 claims description 4
- 235000004279 alanine Nutrition 0.000 claims description 4
- 235000018417 cysteine Nutrition 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 235000006109 methionine Nutrition 0.000 claims description 4
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- 229910000366 copper(II) sulfate Inorganic materials 0.000 claims description 3
- 229910000360 iron(III) sulfate Inorganic materials 0.000 claims description 3
- AACACXATQSKRQG-UHFFFAOYSA-L magnesium;2-aminoacetate Chemical compound [Mg+2].NCC([O-])=O.NCC([O-])=O AACACXATQSKRQG-UHFFFAOYSA-L 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000009697 arginine Nutrition 0.000 claims description 2
- 235000009582 asparagine Nutrition 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229960002591 hydroxyproline Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229940004916 magnesium glycinate Drugs 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- GIPOFCXYHMWROH-UHFFFAOYSA-L 2-aminoacetate;iron(2+) Chemical compound [Fe+2].NCC([O-])=O.NCC([O-])=O GIPOFCXYHMWROH-UHFFFAOYSA-L 0.000 claims 4
- WNUKBOIKJJGIRV-UHFFFAOYSA-L 2-aminoacetate;chromium(2+) Chemical compound [Cr+2].NCC([O-])=O.NCC([O-])=O WNUKBOIKJJGIRV-UHFFFAOYSA-L 0.000 claims 1
- ULRFEZRKKSYJTP-UHFFFAOYSA-K 2-aminoacetate;chromium(3+) Chemical compound [Cr+3].NCC([O-])=O.NCC([O-])=O.NCC([O-])=O ULRFEZRKKSYJTP-UHFFFAOYSA-K 0.000 claims 1
- XCTITUGPTCDTON-UHFFFAOYSA-L 2-aminoacetate;cobalt(2+) Chemical compound [Co+2].NCC([O-])=O.NCC([O-])=O XCTITUGPTCDTON-UHFFFAOYSA-L 0.000 claims 1
- IXONOEXDSRFORV-UHFFFAOYSA-N 2-aminoacetic acid;cobalt Chemical compound [Co].NCC(O)=O.NCC(O)=O IXONOEXDSRFORV-UHFFFAOYSA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 claims 1
- 229940071566 zinc glycinate Drugs 0.000 claims 1
- 239000011686 zinc sulphate Substances 0.000 claims 1
- 235000009529 zinc sulphate Nutrition 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000011575 calcium Substances 0.000 description 33
- -1 iron amino acid Chemical class 0.000 description 33
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 29
- 229910052791 calcium Inorganic materials 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 239000002244 precipitate Substances 0.000 description 18
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 17
- 229910000365 copper sulfate Inorganic materials 0.000 description 17
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 15
- OFNJDDJDXNMTHZ-UHFFFAOYSA-L calcium;2-aminoacetate Chemical compound [Ca+2].NCC([O-])=O.NCC([O-])=O OFNJDDJDXNMTHZ-UHFFFAOYSA-L 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 150000002739 metals Chemical class 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 11
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical group [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 229960001763 zinc sulfate Drugs 0.000 description 9
- 230000009920 chelation Effects 0.000 description 8
- 239000011790 ferrous sulphate Substances 0.000 description 8
- 235000003891 ferrous sulphate Nutrition 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical group [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 5
- ZHUXMBYIONRQQX-UHFFFAOYSA-N hydroxidodioxidocarbon(.) Chemical compound [O]C(O)=O ZHUXMBYIONRQQX-UHFFFAOYSA-N 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 229940099596 manganese sulfate Drugs 0.000 description 4
- 239000011702 manganese sulphate Substances 0.000 description 4
- 235000007079 manganese sulphate Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000003841 chloride salts Chemical class 0.000 description 3
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 3
- CYKLGTUKGYURDP-UHFFFAOYSA-L copper;hydrogen sulfate;hydroxide Chemical compound O.[Cu+2].[O-]S([O-])(=O)=O CYKLGTUKGYURDP-UHFFFAOYSA-L 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940106635 calcium amino acid chelate Drugs 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229940055042 chromic sulfate Drugs 0.000 description 2
- 229910000356 chromium(III) sulfate Inorganic materials 0.000 description 2
- 239000011696 chromium(III) sulphate Substances 0.000 description 2
- 235000015217 chromium(III) sulphate Nutrition 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 229960000355 copper sulfate Drugs 0.000 description 2
- 210000003811 finger Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- XBDUTCVQJHJTQZ-UHFFFAOYSA-L iron(2+) sulfate monohydrate Chemical compound O.[Fe+2].[O-]S([O-])(=O)=O XBDUTCVQJHJTQZ-UHFFFAOYSA-L 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- HZRUTVAFDWTKGD-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;hydrate Chemical compound O.NCCCC[C@H](N)C(O)=O HZRUTVAFDWTKGD-JEDNCBNOSA-N 0.000 description 1
- YJYOLOWXCPIBSY-UHFFFAOYSA-L 2-aminoacetic acid;iron(2+);sulfate Chemical compound [H+].[H+].[Fe+2].NCC([O-])=O.NCC([O-])=O.[O-]S([O-])(=O)=O YJYOLOWXCPIBSY-UHFFFAOYSA-L 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001124569 Lycaenidae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- XUDYDGIFOJLDTL-UHFFFAOYSA-L calcium 2-aminoacetate 2-aminoacetic acid Chemical compound [Ca+2].NCC(O)=O.NCC([O-])=O.NCC([O-])=O XUDYDGIFOJLDTL-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- ZEDVQPMPKANXKG-UHFFFAOYSA-H chromium(3+) trisulfate hexahydrate Chemical compound O.O.O.O.O.O.S(=O)(=O)([O-])[O-].[Cr+3].S(=O)(=O)([O-])[O-].S(=O)(=O)([O-])[O-].[Cr+3] ZEDVQPMPKANXKG-UHFFFAOYSA-H 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910000361 cobalt sulfate Inorganic materials 0.000 description 1
- 229940044175 cobalt sulfate Drugs 0.000 description 1
- 235000014987 copper Nutrition 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229960002306 lysine monohydrate Drugs 0.000 description 1
- 229910001510 metal chloride Inorganic materials 0.000 description 1
- 150000001455 metallic ions Chemical group 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001863 plant nutrition Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to compositions and methods of preparing amino chelates that are free of interfering ions, and optionally, electrically neutral. In one embodiment, the compsosition is prepared by reacting in an aqueous solution a calcium oxide and/or hydroxide, an amino acid, and a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the ions present in solution to react forming a metal amino acid chelate and an essentially inert calcium sulfate, and wherein the metal amino acid chelate has a ligand to metal molar ratio from 2:1 to 3:1. Alternatively, the composition can be prepared by reacting in an aqueous solution, a calcium oxide and/or hydroxide, an amino acid, and a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the ions present in solution to react forming a positively charged metal amino acid chelate having a hydroxide counter-ion, and a calcium sulfate, and wherein the metal amino acid chelate has a ligand to metal molar ratio from 1:1 to 2:1.
Description
A COMPOSITION AND METHOD FOR PREPARING
AMINO ACID CHELATES FREE OF INTERFERING IONS
FIELD OF THE INVENTION
The present invention relates to compositions and methods of preparing amino acid chelates that are essentially free of interfering ions with the proviso a hydr oxide ion is not considered to be interfering. Alternatively, amino acid chelates that are electrically neutral and do not contain hydroxide complex ions can also be formed.
BACKGROUND OF THE INVENTION
Amino acid chelates are generally produced by the reaction between a-amino acids and metal ions having a valence of two or more to form a ring structure. In such a reaction, the positive electrical charge of the metal ion is neutralized by the electrons available through the carboxylate or free amino groups of the a-amino acid.
Traditionally, the term "chelate" has been loosely defined as a combination of a metallic ion bonded to one or more ligands forming heterocyclic ring structures. Under this definition, chelate formation through neutralization of the positive charges of the divalent metal ions may be through the formation of ionic, covalent, or coordinate covalent bonding. An alternative and more modern definition of the term "chelate" requires that the metal ion be bonded to the ligand solely by coordinate covalent bonds forming a heterocyclic ring. In either case, both definitions describe a metal ion and a ligand forming a heterocyclic ring.
A chelate is a definite structure resulting from precise requirement of synthesis. Proper conditions must be present for chelation to take place, including proper mole ratios of ligands to metal ions, pH, and solubility of reactants.
For chelation to occur, all components are generally dissolved in solution and are either ionized or of appropriate electronic configuration in order for coordinate covalent bonding and/or ionic bonding between the ligand and the metal ion to occur.
Chelation can be confirmed and differentiated from mixtures of components by infrared spectra through comparison of the stretching of bonds or shifting of absorption caused by bond formation. As applied in the field of mineral nutrition, there are two allegedly "chelated" products which are commercially utilized. The first is referred to as a "metal proteinate." The American Association of Feed Control officials (AAFCO) has defined a "metal proteinate"
as the product resulting from the chelation of a soluble salt with amino acids and/or partially hydrolyzed protein. Such products are referred to as the specific metal proteinate, e.g., copper proteinate, zinc proteinate, etc. Sometimes, metal proteinates are even referred to as amino acid chelates, though this characterization is not accurate. This is because by definition, a metal proteinate must contain partially hydrolyzed proteins which may or may not be mixed with amino acids.
The second product, referred to as an "amino acid chelate," when properly formed, is a stable product having one or more five-membered rings formed by a reaction between the carboxyl oxygen, and the a-amino group of an a-amino acid with the metal ion. Such a five-membered ring is defined by the metal atom, the carboxyl oxygen, the carbonyl carbon, the a-carbon and the a-amino nitrogen.
The actual structure will depend upon the ligand to metal mole ratio and whether the carboxyl oxygen forms a coordinate covalent bond or an ionic bond with the metal ion. Generally, the ligand to metal molar ratio is at least 1: l and is preferably 2:1 or 3:1. However, in certain instances, the ratio may be 4:1.
Most typically, an amino acid chelate may be represented at a ligand to metal molar ratio of 2:1 according to Formula 1 as follows:
AMINO ACID CHELATES FREE OF INTERFERING IONS
FIELD OF THE INVENTION
The present invention relates to compositions and methods of preparing amino acid chelates that are essentially free of interfering ions with the proviso a hydr oxide ion is not considered to be interfering. Alternatively, amino acid chelates that are electrically neutral and do not contain hydroxide complex ions can also be formed.
BACKGROUND OF THE INVENTION
Amino acid chelates are generally produced by the reaction between a-amino acids and metal ions having a valence of two or more to form a ring structure. In such a reaction, the positive electrical charge of the metal ion is neutralized by the electrons available through the carboxylate or free amino groups of the a-amino acid.
Traditionally, the term "chelate" has been loosely defined as a combination of a metallic ion bonded to one or more ligands forming heterocyclic ring structures. Under this definition, chelate formation through neutralization of the positive charges of the divalent metal ions may be through the formation of ionic, covalent, or coordinate covalent bonding. An alternative and more modern definition of the term "chelate" requires that the metal ion be bonded to the ligand solely by coordinate covalent bonds forming a heterocyclic ring. In either case, both definitions describe a metal ion and a ligand forming a heterocyclic ring.
A chelate is a definite structure resulting from precise requirement of synthesis. Proper conditions must be present for chelation to take place, including proper mole ratios of ligands to metal ions, pH, and solubility of reactants.
For chelation to occur, all components are generally dissolved in solution and are either ionized or of appropriate electronic configuration in order for coordinate covalent bonding and/or ionic bonding between the ligand and the metal ion to occur.
Chelation can be confirmed and differentiated from mixtures of components by infrared spectra through comparison of the stretching of bonds or shifting of absorption caused by bond formation. As applied in the field of mineral nutrition, there are two allegedly "chelated" products which are commercially utilized. The first is referred to as a "metal proteinate." The American Association of Feed Control officials (AAFCO) has defined a "metal proteinate"
as the product resulting from the chelation of a soluble salt with amino acids and/or partially hydrolyzed protein. Such products are referred to as the specific metal proteinate, e.g., copper proteinate, zinc proteinate, etc. Sometimes, metal proteinates are even referred to as amino acid chelates, though this characterization is not accurate. This is because by definition, a metal proteinate must contain partially hydrolyzed proteins which may or may not be mixed with amino acids.
The second product, referred to as an "amino acid chelate," when properly formed, is a stable product having one or more five-membered rings formed by a reaction between the carboxyl oxygen, and the a-amino group of an a-amino acid with the metal ion. Such a five-membered ring is defined by the metal atom, the carboxyl oxygen, the carbonyl carbon, the a-carbon and the a-amino nitrogen.
The actual structure will depend upon the ligand to metal mole ratio and whether the carboxyl oxygen forms a coordinate covalent bond or an ionic bond with the metal ion. Generally, the ligand to metal molar ratio is at least 1: l and is preferably 2:1 or 3:1. However, in certain instances, the ratio may be 4:1.
Most typically, an amino acid chelate may be represented at a ligand to metal molar ratio of 2:1 according to Formula 1 as follows:
R CH 11TH~~ ~,O C O
,, .., O ~ d' ~H N CH-R
Formula 1 In the above formula, the dashed lines represent coordinate covalent bonds, covalent bonds, or ionic bonds. The solid lines between the a-amino group and the metal (M) are covalent or coordinate covalent bonds. Further, when R is H, the amino acid is glycine which is the simplest of the a-amino acids. However, R
could be a radical forming any other of the other twenty or so naturally occurring amino acids derived from proteins. All of the amino acids have the same configuration for the positioning of the carboxyl oxygen and the a-amino nitrogen with respect to the metal ion. In other words, the chelate ring is defined by the same atoms in each instance, even though the R group may vary.
The American Association of Feed Control Officials (AAFCO) have also issued a definition for amino acid chelates. It is officially defined as the product resulting from the reaction of a metal ion from a soluble metal salt with amino acids having a mole ratio of one mole of metal to one to three (preferably two) moles of amino acids to form coordinate covalent bonds. The average weight of the hydrolyzed amino acids must be approximately 150 and the resulting molecular weight of the chelate must not exceed 800. The products are identified by the specific metal forming the chelate, e.g., iron amino acid chelate, copper amino acid chelate, etc.
The reason a metal atom can accept bonds over and above the oxidation state of the metal is due to the nature of chelation. For example, at the a-amino group of an amino acid, the nitrogen contributes both of the electrons used in the bonding. These electrons fill available spaces in the d-orbitals forming a coordinate covalent bond. Thus, a metal ion with a normal valency of +2 can be bonded by four bonds when fully chelated. In this state, the chelate is completely satisfied by the bonding electrons and the charge on the metal atom (as well as on the overall molecule) is zero. As stated previously, it is possible that the metal ion be bonded to the carboxyl oa~ygen by either coordinate covalent bonds or ionic bonds. However, the metal ion is typically bonded to the a-amino group by coordinate covalent bonds only.
Amino acid chelates can also be formed using small peptide ligands instead of single amino acids. These will usually be in the form of dipeptides, tripeptides, and sometimes tetrapeptides because larger ligands have molecular weights that are too great for direct cellular assimilation of the chelate formed.
Generally, peptide ligands will be derived by the hydrolysis of protein. However, peptides prepared by conventional synthetic techniques or genetic engineering can also be used. When a ligand is a di- or tripeptide, a radical of the formula [C(O)CI~NH]e H will replace one of the hydrogens attached to the nitrogen atom in Formula 1. R, as defined in Formula 1, can be H, or the residue of any other naturally occurring amino acid and a can be an integer of 1, 2 or 3.
When a is 1 the ligand will be a dipeptide, when a is 2 the ligand will be a tripeptide and so forth.
The structure, chemistry and bioavailability of amino acid chelates is well documented in the literature, e.g. Ashmead et al., Chelated Mineral Nutrition, (1982), Chas. C. Thomas Publishers, Springfield, Ill.; Ashmead et al., Intestinal Absorption of Metal Ions, (1985), Chas. C. Thomas Publishers, Springfield, Ill.;
Ashmead et al., Foliar Feeding of Plants with Amino Acid Chelates, ( 1986), Noyes Publications, Park Ridge, N.J.; U.S. Patents 4,020,158; 4,167,564;
4,216,143; 4,216,144; 4,599,152; 4,774,089; 4,830,716; 4,863,898; 4,725,427;
and others, the entire teachings of which are incorporated by reference.
One advantage of amino acid chelates in the field of mineral nutrition is attributed to the fact that these chelates are readily absorbed in the absorptive mucosal cells or plant cells by means of active transport or other know mechanisms. In other words, the minerals are absorbed along with the amino acids as a single unit utilizing the amino acids as carrier molecules.
Therefore, the problems associated with the competition of ions for active sites and the suppression of specific nutritive mineral elements by others are avoided. This is especially true for compounds such as iron sulfates that must be delivered in 5 relatively large quantities in order for the body or plant to absorb an appropriate amount. This is significant because large quantities often cause nausea and other gastrointestinal discomforts in animals as well as create an undesirable taste.
Additionally, in plants, large amounts of these compounds can act to burn leaves and cause other undesirable results.
In the past, amino acid chelates have generally been made by first dissolving a water soluble metal salt in water. An amino acid ligand is then reacted with the metal ion at a ratio of ligand to metal from 1:1 to 4:1, preferably 2:1. Often, the ligand is a hydrolysis product obtained by acid, base, base-acid, base-acid-base, or enzyme hydrolysis. In such cases, the by products from hydrolysis, such as anions including chlorides, sulfates, phosphates and nitrates, and cations including potassium and sodium, remain in the hydrolysate.
Reaction products of metal salts with proteins or with acid andlor base hydrolyzed proteins are taught in U.S. Pat. Nos. 2,960,406; 3,396,104; 3,463,858; 3,775,132;
4,020,158; 4,103,003; and 4,172,072.
In fact, most water soluble salts used in making amino acid chelates have been either sulfates or chlorides. Using the sulfate ion as exemplary, the reaction has generally proceeded according to Formula 2 as follows:
2Na~H + MSO~ + 2NHaiHC00H
R
R-CH NH O C=O
+ NazSO~ + 2H20 O=C O~ ~HZN CH-R
Formula 2 where M is a bivalent metal cation and R is a radical of a naturally occurring amino acid, dipeptide or polypeptide. It is apparent from the above formula that the sulfate anion is present in the reaction mixture in the form of sodium sulfate.
U.S. Pat. No. 2,877,253 teaches a product formed by the reaction of one mole of glycine with one mole of ferrous sulfate. That patent indicates that the sulfate anion becomes tied up in the reaction which allegedly forms a ferrous sulfate-glycine complex. Whether the sulfate actually participates in the reaction or is merely present as the salt of an alkali metal, it nevertheless is present in the reaction mixture. Thus, in many cases, the sulfate interferes with the total reaction and absorption of the chelate. Such products are difficult to purify. While sodium sulfate, per se, is water soluble, the reaction between a metal sulfate and an amino acid is never carried to 100% completion and the sulfate ion is always present.
The same holds true for the presence of chloride ions when utilizing a metal chloride salt for amino acid chelate preparation.
Even if one were to attempt to wash out the excess sulfate or chloride ions with repeated washes, such an attempt would likely be counter productive inasmuch as glycine and other amino acid ligands are also soluble to a degree.
Hence, depending upon pH, the unreacted ligands or weakly held ligands could also be removed along with the unwanted anions.
As mentioned, in order to manufacture amino acid chelates, it generally requires that the metal salt and the ligand both be dissolved in water. One problem with this is employing metal salts that are soluble but essentially free from anions that can interfere with the chelation process. This is the subject of U.S.
Patents 4,599,152 and 4,830,716, both of which are incorporated by reference.
In the past, if certain soluble metal salts, such as sulfates, were used as a mineral source for chelation purposes, the resulting anions interfered with the chelation process. For example, the attraction between the lone pair of electrons on the amine group of an amino acid and a hydrogen ion is strong. This is why glycine is represented by the zwitterionic structure +H3NCHZC00-. This strong attraction for the hydrogen ion explains why amino acids are weak acids, e.g., the glycine is not easily deprotonated. In water, only about 0.5% of the glycine typically disassociates and releases a hydrogen ion. Additionally, in the prior art, the introduction of mineral acid salts into solution, such as copper sulfate, resulted in the creation of copper ions which compete with the hydrogen ion for the lone pair of electrons on the NHZ group. Unfortunately, the equilibrium favors tlae majority of the amino groups remaining protonated. Thus, in order to efficiently chelate metal ions from certain soluble salts, it becomes desirable to render the interfering ions inactive or use soluble metal salts with non-interfering ions, such as oxides or hydroxides.
SUMMARY OF THE INVENTION
The present invention can comprise compositions and methods of manufacturing electrically neutral amino acid chelates free of interfering ions.
These amino acid chelates are prepared by reacting an calcium oxide and/or hydroxide, an amino acid, and a soluble metal sulfate salt in an aqueous solution at a ratio sufficient to allow substantially all of the ions present in solution to react.
Thus, a metal amino acid chelate, calcium sulfate, and water are formed with substantially no interfering ions. The metal amino acid chelates produced will have a ligand to metal molar ratio from about 2:1 to 3:1, depending on the valency of the metal, e.g., Fe(II) forms 2: l and Fe(III) forms 3:1.
The present invention can also comprise compositions and methods of manufacturing amino acid chelates free of interfering ions. These amino acid chelates are prepared by reacting calcium oxide or hydroxide, an amino acid, and a soluble metal sulfate salt in an aqueous environment at a ratio sufficient to allow substantially all of the potentially interfering ions present in solution to react.
Thus, a positively charged metal amino acid chelate having a hydroxide counter ion present, an essentially insoluble calcium sulfate salt, and optionally, water are formed without the presence of interfering ions. As stated, for purposes of the present invention, a hydroxide anion is not considered to be interfering. The metal amino acid chelates produced will have a ligand to metal molar ratio from about 1:1 to 2:1, depending on the valency of the metal, e.g., Fe(II) forms 1:1 and Fe(III) forms 2: I.
DETAILED DESCRIPTION OF THE INVENTION
Before the present invention is disclosed and described, it is to be understood that this invention is not limited to the particular process steps and materials disclosed herein because such process steps and materials may vary somewhat. It is also to be understood that the terminology used herein is used for the purpose of describing particular embodiments only. The terms are not intended to be limiting because the scope of the present invention is intended to be limited only by the appended claims and equivalents thereof.
It must be noted that, as used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the content I S clearly dictates otherwise.
"Electrically neutral" refers to the amino acid chelate of the reaction in: ~
~' which essentially all of the reactants have formed product such that there is no net charge on the amino acid chelate itself. Embodiments where the amino acid chelate is positively charged and is complexed to a hydroxide counter ion are not considered to be electrically neutral, even though the net charge of the entire complex, i.e., amino acid chelate and hydroxide ion, is neutral.
"Interfering ion" is meant to include any cation or anion which would hinder the formation of the amino acid chelate and which remains in the composition as a charged ion that has not reacted to form an amino acid chelate, calcium sulfate, or water. Alternatively, in some embodiments, "interfering ion"
can include any ration or anion which would hinder the formation of the amino acid chelate and which remains in the composition as a charged ion that has not reacted to form either the charged amino acid chelate having a hydroxide counter-ion or the calcium sulfate salt. For purposes of the present invention, a hydroxide anion which is preferably complexed to the positively charged amino acid chelate is not considered to be an interfering ion.
"Metal amino acid chelate" or "amino acid chelate" includes metal ions bonded to amino acid ligands forming heterocyclic rings. The bonds may be coordinate covalent, covalent andlor ionic at the carboxyl oxygen group.
However, at the a-amino group, the bond is typically a coordinate covalent bond.
Preferred amino acids include all of the naturally occurring amino acids. In one embodiment, the amino acid chelate formed is electrically neutral.
Alternatively, in another embodiment, "amino acid chelate" can include any charged amino acid chelate that is electrically balanced by a hydroxide counter ion. For example, a trivalent cation having a ligand to metal molar ratio of 2:1 may be represented by the formula M'(AA)Z+OH- where M' is the trivalent metal and AA is an amino acid. Additionally, a divalent cation having a ligand to metal molar ratio of 1:1 may be represented by the formula M(AA)~OH- where M is the divalent metal and AA is an amino acid. If the amino acid chelate as a whole is in solution, the hydroxide anion and the charged chelate may be in solution or complexed together. If the amino acid chelate has been dried, the hydroxide anion and the charged chelate will likely be complexed.
"Metal" is meant to cover all nutritionally relevant metals that are more soluble as sulfate salts than calcium sulfate. Though calcium is a metal, for purposes of the present disclosure, calcium is specifically excluded within this definition unless the context clearly dictates otherwise.
"Soluble metal sulfate" or "soluble metal sulfate salt" include all divalent or trivalent metals that are more soluble than calcium sulfate when in the form of a sulfate salt. Preferred soluble metal sulfate salts can comprise at least one nutritionally relevant metal.
"Nutritionally relevant metals" include metals that are known to be needed by living organisms, particularly plants and mammals, including humans. Metals such as copper (Cu), zinc (Zn), iron (Fe), cobalt (Co), magnesium (Mg), manganese (Mn), and/or chromium (Cr), among others, are exemplary of nutritionally relevant metals.
With this in mind, in one embodiment, the present invention includes compositions and methods of manufacturing electrically neutral amino acid 5 chelates free of interfering ions. These chelates are prepared by reacting 1) calcium oxide and/or hydroxide, 2) one or more amino acid, and 3) a soluble riletal sulfate salt in an aqueous solution at a ratio sufficient to allow substantially all of the ions present in solution to react forming a metal amino acid chelate, calcium sulfate, and water, and wherein the metal amino acid chelate has a ligand to metal 10 molar ratio from about 2:1 to 3:1.
In an alternative embodiment, the present invention includes compositions and methods of manufacturing amino acid chelates free of interfering ions.
These chelates are prepared by reacting 1) a calcium oxide or hydroxide, 2) an amino acid, and 3) a soluble metal sulfate salt in an aqueous environment at a ratio sufficient to allow substantially all of the ions present in solution to react forming a positively charged metal amino acid chelate having a hydroxide counter-ion, a calcium sulfate salt, and optionally, water. Further, the metal amino acid chelates of the present invention will have a ligand to metal molar ratio from about 1:1 to 2:1.
The embodiments described above are similar to one another in that both result in compositions that are free of interfering ions. However, in the former embodiment, an electrically neutral amino acid chelate is formed having a ligand to metal molar ratio from about 2:1 to 3:1. In the latter embodiment, compositions and methods of preparing amino acid chelates that are positively charged having a hydroxide counter ion, and which have a ligand to metal molar ratio from about 1:1 to 2:1 are disclosed.
It is noteworthy that though the compositions and methods of the present invention provide amino acid chelates free of interfering ions, calcium sulfate is always a byproduct. Therefore, the calcium sulfate may be substantially separated out of the compound by methods commonly known in the art. Alternatively, the calcium sulfate may remain in the compound as a stabilizer or for other purposes as described herein.
The present invention also encompasses drying of the chelate solution when appropriate to provide a powder for some uses, e.g., human, animal, and plant nutrition. However, with some applications, it may be desired that the chelate remain in solution, e.g., foliar use. If drying the chelate to form a particulate, any conventional drying technique as is known in the art may be used.
For example, if spray drying, bulk density of the powder produced in a spray dryer is affected by the mesh size of the nozzles in the dryer, the pump pressure, and the percent of total solids in the solution to be dried. In general, the higher the total solids, the greater the bulk density of the resulting powder. A greater bulk density also reduces the electrostatic properties of the spray dried powder. For example, the presence of the calcium sulfate (terra alba) suspended in the metal amino acid chelate solution by continual agitation will increase the total solids to be dried, thus, increasing the ultimate bulk density of the dried chelate.
The increased bulls density of the dried product may have at least three distinct advantages. First, the dried product is less hygroscopic due to the increased density and due to the fact that calcium sulfate salt is less hygroscopic than the amino acid chelate, which through the drying process have waters of hydration removed. Second, a more dense particle is less electrostatic. This potentially reduces the cleanup time in a mixer when the chelate is blended with other food or pharmaceutical substances and enhances mixing characteristics when powdered chelates are blended with these other substances. Third, when the amino acid chelate is mixed with calcium sulfate, the presence of calcium sulfate stabilizes the amino acid chelate in an acidic solution.
With respect to either embodiment, the amino acid to be used can be one or more of the naturally occurring amino acid selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, cystine, glutanvne, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and combinations thereof. However, dipeptides, ti~ipeptides, and tetrapeptides formed by any combination of the naturally occurring amino acids can also be used. The metal is preferably more soluble as a sulfate salt than calcium sulfate. Exemplary metals for use can include those selected from the group consisting of Cu, Zn, Fe, Cr, Co, Mg, Mn, and combinations thereof.
Therefore, the metal reactant is preferably provided as a sulfate salt selected from the group consisting of copper sulfate (CuS04), zinc sulfate (ZnS04), ferrous sulfate (FeS04), manganese sulfate (MnSO4), cobalt sulfate (CoSO~), magnesium sulfate (MgS04), ferric sulfate [Fe2(S04)3], chromic sulfate [Crz(S04)3], and combinations thereof.
While not wanting to be bound by any theory, a possible mechanism describing the reaction by which the amino acid chelates of the present invention are prepared may be broken down into two steps. Step A involves the reaction of one or more amino acids) with a soluble calcium oxide and/or hydroxide in an aqueous solution forming a calcium amino acid chelate or complex product. Step B involves the reaction of a soluble metal sulfate salt with the calcium amino acid chelate or complex product formed in Step A. In one embodiment, the calcium is displaced by the metal forming an electrically neutral amino acid chelate having a ligand to metal molar ratio from 2:1 to 3:1. In another embodiment, the calcium is displaced by the metal forming an amino acid chelate having a ligand to metal molar ratio from 1:1 to 2:1, and having a hydroxide counter ion. In both embodiments, the calcium reacts with the sulfate anion to form an inert and highly insoluble calcium sulfate precipitate.
Certain individual embodiments will be described with more particularity below.
Prepanatiora Of Electrically Neutral Amino Acid Chelates The reactions used to prepare electrically neutral amino acid chelates essentially free of interfering ions and having a ligand to metal molar ratio from about 2:1 to 3:1 are shown below. Formulas 3a and 3b illustrate the production of an amino acid chelate having a 2:1 ligand to metal molar ratio:
Ca(OH)a + 2H(AA) Water] Ca(~)z + 2HZo Ca(AA)z + MS04 watery M(~)2 + CaS04 Formula 3a Ca0 + 2H(AA) Water> Ca(AA)2 + H20 Ca(AA)z + MSO4 Water> M(~)2 + CaS04 Formula 3b In Formulas 3a and 3b above and 4a and 4b below, H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof. H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid. M is a nutritionally relevant metal having a valency of +2 (excluding calcium) such as Cu, Zn, Fe, Co, Mg, and/or Mn.
To illustrate this mechanism further, consider the reactants copper sulfate, calcium oxide, and glycine. First, one mole of calcium oxide is reacted with two moles of glycine. After allowing the calcium and glycine to react, copper sulfate is added. The log of the equilibrium constant at zero ionic strength for the reaction Ca2+ + (Gly)' H Ca(Gly)''-, where (Gly)' represents a glycine anion, is 1.39.
By comparison, for the same reaction with copper rather than calcium, the log of the equilibrium constant is x.56. Though a literature value is not given for the equilibrium constant for the attachment of two glycinate anions to a calcium canon, the principle that copper has stronger affinity for glycine ligands than does calcium is demonstrated by these values.
It is important to note that the reactants, i.e., CaO, H(AA), and MSO4, may be added in any order. For example, all three reactants may be added simultaneously or the amino acid and the soluble metal salt may be added before the calcium oxide or hydroxide. However, the above equation must be balanced so that the final products, M(AA)2, CaS04, and water, are free of interfering ions such that the amino acid chelate is electrically neutral. Therefore, notwithstanding Formula 3a and 3b which illustrates a preferred mechanism, the general formula of the present invention when a 2:1 ligand to metal molar ratio is desired may be represented by Formulas 4a and 4b as follows:
Ca(OH)2+ 2H(AA) + MS04 Wate''> M(AA)2 + CaS04 + 2H20 Formula 4a Ca0 + 2H(AA) + MS04 Water] M(H)z + CaS04 + H20 Formula 4b For purposes of the present invention, multiple metals, amino acids, salts, etc., may be used in the context of the present invention as well. However, metals having a proper valency state should be used, e.g., Cu, Zn, Fe(II), Co, Mg, and/or Mn for amino acid chelates having a ligand to metal molax ratio of about 2:1.
General Formulas 4a and 4b above may be modified to prepare amino acid chelates having a ligand to metal molar ratio of about 3:1 using metals having a valency of +3, e.g., Fe(III), Cr, etc. The general formula of the present invention when a 3:1 ligand to metal molar ratio is desired may be represented by Formulas Sa and Sb as follows:
3Ca(OH)z+ 6H(AA) + M'Z(S04)3 Wa'e~ 2M'(AA)3 + 3CaS0~ + 6H20 Formula Sa 3Ca0 + 6H(AA) + M'2(SO4)3 Water 2M'(AA)3 + 3CaS0ø + 3HZo Formula 5b In Formulas Sa and Sb, H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof. H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present 5 on the amino acid. M' is a nutritionally relevant metal having a valence of +3 such as Fe(III) and/or Cr.
It is important to note that though the compositions and methods of the present invention provide electrically neutral amino acid chelates free of interfering ions, calcium sulfate is always a byproduct. Therefore, the calcium 10 sulfate may be substantially separated out of the compound by methods commonly known in the art while the chelate is still in solution. Alternatively, the calcium sulfate may remain in the compound as a stabilizer or for other purposes.
To cite a specific example of a pure and electrically neutral amino acid chelate having a ligand to metal molar ratio of about 2:1, the following reactions 15 steps may be followed. First, one mole of calcium oxide (Ca0) may be reacted with two moles of glycine to form a reaction product of calcium bisglycinate in water. The problems associated with a hydrogen ion being bound to the amine group are resolved because it has reacted with the oxygen from the Ca0 to form water. To this solution, one mole of copper sulfate (CuS04) is added. This allows for the disassociated copper ions to react with the calcium bisglycinate as the strength of bonding between the copper and the glycinate anion is stronger than the calcium glycinate bond. As such, the calcium is displaced by the copper forming copper bisglycinate. The calcium ions that are displaced in turn react with the sulfate anions (from the CuSOø) forming calcium sulfate which is sparingly soluble and essentially inert.
P~epaYatio~e Of Positively Charged Amiho Acid Chelates Having Hydroxide Counter-Ions The reactions used to prepare amino acid chelates essentially free of interfering ions and having a ligand to metal molar ratio from about 1:1 to 2:1 are shown below. Formulas 6a and 6b illustrate the production of an amino acid chelate having a 1:1 ligand to metal molar ratio:
Ca(OH)2 + H(AA) wateh Ca(AA)*OH' + H20 Ca(AA)+OH' + MS04 "'ate M(AA)+OH' + CaS04 Formula 6a Ca0 + H(AA) Water Ca(AA)+OH' Ca(AA)+OH' + MSO,~ a'ateh M(AA)~OH' + CaSO~
Formula 6b In Formulas 6a, 6b above and Formulas 7a and 7b below, (H)AA is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof. H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid. M is a nutritionally relevant metal having a valency of +2 (excluding calcium) such as Cu, Zn, Fe, Co, Mg, andlor Mn.
To illustrate this mechanism fixrther, consider the reactants copper sulfate, calcium oxide, and glycine. First, one mole of calcium oxide is reacted with one mole of glycine. After allowing the calcium and glycine to react, copper sulfate is added. The log of the equilibrium constant at zero ionic strength for the reaction Ca2+ + (Gly)' ~ Ca(Gly)+, where (Gly)' represents a glycine anion, is 1.39. By comparison, for the same reaction with copper rather than calcium, the log of the equilibrium constant is 8.56. Thus, these values demonstrate that copper has stronger affinity for the glycine ligand than does the calcium.
It is important to note that the added reactants, i.e., Ca0 or Ca(OH)2, H(AA), and MS04, may be added in any order. For example, all three reactants may be added simultaneously or the amino acid and the soluble metal sulfate salt may be added before the calcium oxide or hydroxide. However, the above equation must be balanced to account for all of the potential interfering ions so that the final product (which includes M(AA)+OH' + CaS04) is free of interfering ions. Therefore, notwithstanding Formula 6a and 6b which illustrates the above mechanism, the general formula of the present invention when a 1:1 ligand to metal molar ratio is desired may be represented by Formulas 7a and 7b below:
Ca(OH)2 + H(AA) + MS04 Water] M(~)+OH' + CaS04 + H20 Formula 7a Ca0 + H(AA) + MS04 Water] M(~)+OH_ + CaSOø
Formula 7b For purposes of the present invention, multiple soluble metal sulfate salts, amino acids, etc., may also be used. However, metals with proper oxidation states or valency should be used, e.g., Cu, Zn, Fe(II), Co, Mg, and/or Mn when ~ producing amino acid chelates having a ligand to metal molar ratio of about 1:1.
General Formulas 7a and 7b above may be modified to prepare amino acid chelates having a ligand to metal molar ratio of about 2:1 using nutritionally relevant metals having a valency of +3, e.g., Fe(III), Cr, etc. The general formula of the present invention when a 2:1 ligand to metal molar ratio is desired may be represented by Formulas 8a and 8b below:
3Ca(OH)2+ 4H(AA) + M'2(S04)3 Water 2[M'(AA)2+OH'~~+ 3CaS04 + 4H20 Formula 8a 3Ca,0 + 4H(AA) + M'2(SO4)3 Water 2[M'(AA)2+OH'] + 3CaS04 + H20 Formula 8b In Formulas 8a and 8b, H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof; H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid. M' is a nutritionally relevant metal having a valence of +3 such as Fe(III) and/or Cr.
EXAMPLES
The following examples illustrate methods of preparing amino acid chelates that are essentially free of interfering ions. These examples should not be considered as limitations of the present invention, but should merely teach how to make the best known amino acid chelates based upon current experimental data.
Each of the composition examples described herein provide an amount of chalets product produced in solution. However, often, the step of drying, i.e., removing moisture, from a chalets solution may be preferred. Additionally, prior to drying, calcium sulfate (terra alba) may be substantially removed by separation techniques known by those skilled in the art if desired.
P>"eparatiort Of Electrically Neutral Amino Acid Chelates Example 1 - Preparation of copper glycine amino acid chalets Into about 923 grams of water was dissolved 150.14 grams of glycine.
Next, 57.25 grams of calcium oxide, which was about 70% calcium by weight, was added. The solution was continually stirred until all of the calcium oxide was dissolved. This took about 15 minutes. No heat was applied for this particular reaction, though heat could optionally be used in this or other examples. The resulting reaction formed a calcium bisglycinate chalets or complex and water, i. e., the hydrogen ions were removed from the glycine and the oxygen was removed from the calcium oxide.
Next, 254.18 grams of copper sulfate hydrate containing 25% copper by weight was added to the calcium chalets solution. Again, the solution was constantly stirred while the copper sulfate was dissolved. As the copper sulfate went into solution, a white precipitate of calcium sulfate formed. Upon completion of the reaction, about 214 grams of a copper glycine chelate having a ligand to metal molar ratio of 2:1 was formed.
Example 2 - Preparation of zinc glycine amino acid chelate S About 250 grams of glycine was dissolved into 937.8 grams of water.
Once the glycine was significantly dissolved, about 95 grams of calcium oxide was added. The solution was continually stirred for about 15 minutes until all of the calcium was dissolved. The resulting reaction formed a calcium bisglycinate chelate or complex and water.
Next, 299.97 grams of zinc sulfate hydrate containing 35% zinc by weight was added to the calcium chelate solution. Upon constant stirring, the zinc sulfate went into solution and a white precipitate of calcium sulfate formed. About grams of a zinc glycine chelate having a ligand to metal molar ratio of about 2:1 was formed. .
Example 3 - Preparation of manganese glycine amino acid chelate In about 1000 grams of water was dissolved 203.27 grams of glycine and 76.38 grams of calcium oxide. The solution was continually stirred until all of the calcium oxide was dissolved. This took about 15 minutes. No heat was applied for this particular reaction. A calcium bisglycinate chelate or complex aqueous solution was formed.
To the calcium bisglycinate chelate solution was added 272.38 grams of manganese sulfate hydrate containing 27% manganese by weight. Again, the solution was constantly stirred while the manganese sulfate was significantly dissolved. As the manganese sulfate went into solution, a white precipitate of calcium sulfate formed. About 277 grams of a manganese bisglycinate chelate was formed.
Exam~Ie 4 - Preparation of mahgaytese glycihe amiyao acid chelate The procedure of Example 3 may be followed using 100.82 grams of calcium hydroxide instead of 76.38 grams calcium oxide with similar results, i.e., about 277 grams of a manganese bisglycinate is formed, though more water is 5 formed in the reaction.
Example 5 - Preparation of magnesium glycihe amino acid chelate Into about 1500 graxes of water was dissolved 155.63 grams of glycine.
Next, 58.97 grams of calcium oxide, which was 70% calcium by weight, was also 10 added. The solution was continually stirred until all of the calcium oxide was essentially completely dissolved. Again, no heat was applied to the reaction.
A
calcium bisglycinate chelate or complex solution containing excess water was formed.
Next, 572.02 grams of magnesium sulfate hydrate containing 9.86%
15 magnesium by weight was added to the calcium chelate solution. The solution was stirred while the magnesium sulfate dissolved and a white precipitate of calcium sulfate formed. About 211 grams of a magnesium glycinate was formed having a 1:1 ligand to metal molar ratio.
,, .., O ~ d' ~H N CH-R
Formula 1 In the above formula, the dashed lines represent coordinate covalent bonds, covalent bonds, or ionic bonds. The solid lines between the a-amino group and the metal (M) are covalent or coordinate covalent bonds. Further, when R is H, the amino acid is glycine which is the simplest of the a-amino acids. However, R
could be a radical forming any other of the other twenty or so naturally occurring amino acids derived from proteins. All of the amino acids have the same configuration for the positioning of the carboxyl oxygen and the a-amino nitrogen with respect to the metal ion. In other words, the chelate ring is defined by the same atoms in each instance, even though the R group may vary.
The American Association of Feed Control Officials (AAFCO) have also issued a definition for amino acid chelates. It is officially defined as the product resulting from the reaction of a metal ion from a soluble metal salt with amino acids having a mole ratio of one mole of metal to one to three (preferably two) moles of amino acids to form coordinate covalent bonds. The average weight of the hydrolyzed amino acids must be approximately 150 and the resulting molecular weight of the chelate must not exceed 800. The products are identified by the specific metal forming the chelate, e.g., iron amino acid chelate, copper amino acid chelate, etc.
The reason a metal atom can accept bonds over and above the oxidation state of the metal is due to the nature of chelation. For example, at the a-amino group of an amino acid, the nitrogen contributes both of the electrons used in the bonding. These electrons fill available spaces in the d-orbitals forming a coordinate covalent bond. Thus, a metal ion with a normal valency of +2 can be bonded by four bonds when fully chelated. In this state, the chelate is completely satisfied by the bonding electrons and the charge on the metal atom (as well as on the overall molecule) is zero. As stated previously, it is possible that the metal ion be bonded to the carboxyl oa~ygen by either coordinate covalent bonds or ionic bonds. However, the metal ion is typically bonded to the a-amino group by coordinate covalent bonds only.
Amino acid chelates can also be formed using small peptide ligands instead of single amino acids. These will usually be in the form of dipeptides, tripeptides, and sometimes tetrapeptides because larger ligands have molecular weights that are too great for direct cellular assimilation of the chelate formed.
Generally, peptide ligands will be derived by the hydrolysis of protein. However, peptides prepared by conventional synthetic techniques or genetic engineering can also be used. When a ligand is a di- or tripeptide, a radical of the formula [C(O)CI~NH]e H will replace one of the hydrogens attached to the nitrogen atom in Formula 1. R, as defined in Formula 1, can be H, or the residue of any other naturally occurring amino acid and a can be an integer of 1, 2 or 3.
When a is 1 the ligand will be a dipeptide, when a is 2 the ligand will be a tripeptide and so forth.
The structure, chemistry and bioavailability of amino acid chelates is well documented in the literature, e.g. Ashmead et al., Chelated Mineral Nutrition, (1982), Chas. C. Thomas Publishers, Springfield, Ill.; Ashmead et al., Intestinal Absorption of Metal Ions, (1985), Chas. C. Thomas Publishers, Springfield, Ill.;
Ashmead et al., Foliar Feeding of Plants with Amino Acid Chelates, ( 1986), Noyes Publications, Park Ridge, N.J.; U.S. Patents 4,020,158; 4,167,564;
4,216,143; 4,216,144; 4,599,152; 4,774,089; 4,830,716; 4,863,898; 4,725,427;
and others, the entire teachings of which are incorporated by reference.
One advantage of amino acid chelates in the field of mineral nutrition is attributed to the fact that these chelates are readily absorbed in the absorptive mucosal cells or plant cells by means of active transport or other know mechanisms. In other words, the minerals are absorbed along with the amino acids as a single unit utilizing the amino acids as carrier molecules.
Therefore, the problems associated with the competition of ions for active sites and the suppression of specific nutritive mineral elements by others are avoided. This is especially true for compounds such as iron sulfates that must be delivered in 5 relatively large quantities in order for the body or plant to absorb an appropriate amount. This is significant because large quantities often cause nausea and other gastrointestinal discomforts in animals as well as create an undesirable taste.
Additionally, in plants, large amounts of these compounds can act to burn leaves and cause other undesirable results.
In the past, amino acid chelates have generally been made by first dissolving a water soluble metal salt in water. An amino acid ligand is then reacted with the metal ion at a ratio of ligand to metal from 1:1 to 4:1, preferably 2:1. Often, the ligand is a hydrolysis product obtained by acid, base, base-acid, base-acid-base, or enzyme hydrolysis. In such cases, the by products from hydrolysis, such as anions including chlorides, sulfates, phosphates and nitrates, and cations including potassium and sodium, remain in the hydrolysate.
Reaction products of metal salts with proteins or with acid andlor base hydrolyzed proteins are taught in U.S. Pat. Nos. 2,960,406; 3,396,104; 3,463,858; 3,775,132;
4,020,158; 4,103,003; and 4,172,072.
In fact, most water soluble salts used in making amino acid chelates have been either sulfates or chlorides. Using the sulfate ion as exemplary, the reaction has generally proceeded according to Formula 2 as follows:
2Na~H + MSO~ + 2NHaiHC00H
R
R-CH NH O C=O
+ NazSO~ + 2H20 O=C O~ ~HZN CH-R
Formula 2 where M is a bivalent metal cation and R is a radical of a naturally occurring amino acid, dipeptide or polypeptide. It is apparent from the above formula that the sulfate anion is present in the reaction mixture in the form of sodium sulfate.
U.S. Pat. No. 2,877,253 teaches a product formed by the reaction of one mole of glycine with one mole of ferrous sulfate. That patent indicates that the sulfate anion becomes tied up in the reaction which allegedly forms a ferrous sulfate-glycine complex. Whether the sulfate actually participates in the reaction or is merely present as the salt of an alkali metal, it nevertheless is present in the reaction mixture. Thus, in many cases, the sulfate interferes with the total reaction and absorption of the chelate. Such products are difficult to purify. While sodium sulfate, per se, is water soluble, the reaction between a metal sulfate and an amino acid is never carried to 100% completion and the sulfate ion is always present.
The same holds true for the presence of chloride ions when utilizing a metal chloride salt for amino acid chelate preparation.
Even if one were to attempt to wash out the excess sulfate or chloride ions with repeated washes, such an attempt would likely be counter productive inasmuch as glycine and other amino acid ligands are also soluble to a degree.
Hence, depending upon pH, the unreacted ligands or weakly held ligands could also be removed along with the unwanted anions.
As mentioned, in order to manufacture amino acid chelates, it generally requires that the metal salt and the ligand both be dissolved in water. One problem with this is employing metal salts that are soluble but essentially free from anions that can interfere with the chelation process. This is the subject of U.S.
Patents 4,599,152 and 4,830,716, both of which are incorporated by reference.
In the past, if certain soluble metal salts, such as sulfates, were used as a mineral source for chelation purposes, the resulting anions interfered with the chelation process. For example, the attraction between the lone pair of electrons on the amine group of an amino acid and a hydrogen ion is strong. This is why glycine is represented by the zwitterionic structure +H3NCHZC00-. This strong attraction for the hydrogen ion explains why amino acids are weak acids, e.g., the glycine is not easily deprotonated. In water, only about 0.5% of the glycine typically disassociates and releases a hydrogen ion. Additionally, in the prior art, the introduction of mineral acid salts into solution, such as copper sulfate, resulted in the creation of copper ions which compete with the hydrogen ion for the lone pair of electrons on the NHZ group. Unfortunately, the equilibrium favors tlae majority of the amino groups remaining protonated. Thus, in order to efficiently chelate metal ions from certain soluble salts, it becomes desirable to render the interfering ions inactive or use soluble metal salts with non-interfering ions, such as oxides or hydroxides.
SUMMARY OF THE INVENTION
The present invention can comprise compositions and methods of manufacturing electrically neutral amino acid chelates free of interfering ions.
These amino acid chelates are prepared by reacting an calcium oxide and/or hydroxide, an amino acid, and a soluble metal sulfate salt in an aqueous solution at a ratio sufficient to allow substantially all of the ions present in solution to react.
Thus, a metal amino acid chelate, calcium sulfate, and water are formed with substantially no interfering ions. The metal amino acid chelates produced will have a ligand to metal molar ratio from about 2:1 to 3:1, depending on the valency of the metal, e.g., Fe(II) forms 2: l and Fe(III) forms 3:1.
The present invention can also comprise compositions and methods of manufacturing amino acid chelates free of interfering ions. These amino acid chelates are prepared by reacting calcium oxide or hydroxide, an amino acid, and a soluble metal sulfate salt in an aqueous environment at a ratio sufficient to allow substantially all of the potentially interfering ions present in solution to react.
Thus, a positively charged metal amino acid chelate having a hydroxide counter ion present, an essentially insoluble calcium sulfate salt, and optionally, water are formed without the presence of interfering ions. As stated, for purposes of the present invention, a hydroxide anion is not considered to be interfering. The metal amino acid chelates produced will have a ligand to metal molar ratio from about 1:1 to 2:1, depending on the valency of the metal, e.g., Fe(II) forms 1:1 and Fe(III) forms 2: I.
DETAILED DESCRIPTION OF THE INVENTION
Before the present invention is disclosed and described, it is to be understood that this invention is not limited to the particular process steps and materials disclosed herein because such process steps and materials may vary somewhat. It is also to be understood that the terminology used herein is used for the purpose of describing particular embodiments only. The terms are not intended to be limiting because the scope of the present invention is intended to be limited only by the appended claims and equivalents thereof.
It must be noted that, as used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the content I S clearly dictates otherwise.
"Electrically neutral" refers to the amino acid chelate of the reaction in: ~
~' which essentially all of the reactants have formed product such that there is no net charge on the amino acid chelate itself. Embodiments where the amino acid chelate is positively charged and is complexed to a hydroxide counter ion are not considered to be electrically neutral, even though the net charge of the entire complex, i.e., amino acid chelate and hydroxide ion, is neutral.
"Interfering ion" is meant to include any cation or anion which would hinder the formation of the amino acid chelate and which remains in the composition as a charged ion that has not reacted to form an amino acid chelate, calcium sulfate, or water. Alternatively, in some embodiments, "interfering ion"
can include any ration or anion which would hinder the formation of the amino acid chelate and which remains in the composition as a charged ion that has not reacted to form either the charged amino acid chelate having a hydroxide counter-ion or the calcium sulfate salt. For purposes of the present invention, a hydroxide anion which is preferably complexed to the positively charged amino acid chelate is not considered to be an interfering ion.
"Metal amino acid chelate" or "amino acid chelate" includes metal ions bonded to amino acid ligands forming heterocyclic rings. The bonds may be coordinate covalent, covalent andlor ionic at the carboxyl oxygen group.
However, at the a-amino group, the bond is typically a coordinate covalent bond.
Preferred amino acids include all of the naturally occurring amino acids. In one embodiment, the amino acid chelate formed is electrically neutral.
Alternatively, in another embodiment, "amino acid chelate" can include any charged amino acid chelate that is electrically balanced by a hydroxide counter ion. For example, a trivalent cation having a ligand to metal molar ratio of 2:1 may be represented by the formula M'(AA)Z+OH- where M' is the trivalent metal and AA is an amino acid. Additionally, a divalent cation having a ligand to metal molar ratio of 1:1 may be represented by the formula M(AA)~OH- where M is the divalent metal and AA is an amino acid. If the amino acid chelate as a whole is in solution, the hydroxide anion and the charged chelate may be in solution or complexed together. If the amino acid chelate has been dried, the hydroxide anion and the charged chelate will likely be complexed.
"Metal" is meant to cover all nutritionally relevant metals that are more soluble as sulfate salts than calcium sulfate. Though calcium is a metal, for purposes of the present disclosure, calcium is specifically excluded within this definition unless the context clearly dictates otherwise.
"Soluble metal sulfate" or "soluble metal sulfate salt" include all divalent or trivalent metals that are more soluble than calcium sulfate when in the form of a sulfate salt. Preferred soluble metal sulfate salts can comprise at least one nutritionally relevant metal.
"Nutritionally relevant metals" include metals that are known to be needed by living organisms, particularly plants and mammals, including humans. Metals such as copper (Cu), zinc (Zn), iron (Fe), cobalt (Co), magnesium (Mg), manganese (Mn), and/or chromium (Cr), among others, are exemplary of nutritionally relevant metals.
With this in mind, in one embodiment, the present invention includes compositions and methods of manufacturing electrically neutral amino acid 5 chelates free of interfering ions. These chelates are prepared by reacting 1) calcium oxide and/or hydroxide, 2) one or more amino acid, and 3) a soluble riletal sulfate salt in an aqueous solution at a ratio sufficient to allow substantially all of the ions present in solution to react forming a metal amino acid chelate, calcium sulfate, and water, and wherein the metal amino acid chelate has a ligand to metal 10 molar ratio from about 2:1 to 3:1.
In an alternative embodiment, the present invention includes compositions and methods of manufacturing amino acid chelates free of interfering ions.
These chelates are prepared by reacting 1) a calcium oxide or hydroxide, 2) an amino acid, and 3) a soluble metal sulfate salt in an aqueous environment at a ratio sufficient to allow substantially all of the ions present in solution to react forming a positively charged metal amino acid chelate having a hydroxide counter-ion, a calcium sulfate salt, and optionally, water. Further, the metal amino acid chelates of the present invention will have a ligand to metal molar ratio from about 1:1 to 2:1.
The embodiments described above are similar to one another in that both result in compositions that are free of interfering ions. However, in the former embodiment, an electrically neutral amino acid chelate is formed having a ligand to metal molar ratio from about 2:1 to 3:1. In the latter embodiment, compositions and methods of preparing amino acid chelates that are positively charged having a hydroxide counter ion, and which have a ligand to metal molar ratio from about 1:1 to 2:1 are disclosed.
It is noteworthy that though the compositions and methods of the present invention provide amino acid chelates free of interfering ions, calcium sulfate is always a byproduct. Therefore, the calcium sulfate may be substantially separated out of the compound by methods commonly known in the art. Alternatively, the calcium sulfate may remain in the compound as a stabilizer or for other purposes as described herein.
The present invention also encompasses drying of the chelate solution when appropriate to provide a powder for some uses, e.g., human, animal, and plant nutrition. However, with some applications, it may be desired that the chelate remain in solution, e.g., foliar use. If drying the chelate to form a particulate, any conventional drying technique as is known in the art may be used.
For example, if spray drying, bulk density of the powder produced in a spray dryer is affected by the mesh size of the nozzles in the dryer, the pump pressure, and the percent of total solids in the solution to be dried. In general, the higher the total solids, the greater the bulk density of the resulting powder. A greater bulk density also reduces the electrostatic properties of the spray dried powder. For example, the presence of the calcium sulfate (terra alba) suspended in the metal amino acid chelate solution by continual agitation will increase the total solids to be dried, thus, increasing the ultimate bulk density of the dried chelate.
The increased bulls density of the dried product may have at least three distinct advantages. First, the dried product is less hygroscopic due to the increased density and due to the fact that calcium sulfate salt is less hygroscopic than the amino acid chelate, which through the drying process have waters of hydration removed. Second, a more dense particle is less electrostatic. This potentially reduces the cleanup time in a mixer when the chelate is blended with other food or pharmaceutical substances and enhances mixing characteristics when powdered chelates are blended with these other substances. Third, when the amino acid chelate is mixed with calcium sulfate, the presence of calcium sulfate stabilizes the amino acid chelate in an acidic solution.
With respect to either embodiment, the amino acid to be used can be one or more of the naturally occurring amino acid selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, cystine, glutanvne, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and combinations thereof. However, dipeptides, ti~ipeptides, and tetrapeptides formed by any combination of the naturally occurring amino acids can also be used. The metal is preferably more soluble as a sulfate salt than calcium sulfate. Exemplary metals for use can include those selected from the group consisting of Cu, Zn, Fe, Cr, Co, Mg, Mn, and combinations thereof.
Therefore, the metal reactant is preferably provided as a sulfate salt selected from the group consisting of copper sulfate (CuS04), zinc sulfate (ZnS04), ferrous sulfate (FeS04), manganese sulfate (MnSO4), cobalt sulfate (CoSO~), magnesium sulfate (MgS04), ferric sulfate [Fe2(S04)3], chromic sulfate [Crz(S04)3], and combinations thereof.
While not wanting to be bound by any theory, a possible mechanism describing the reaction by which the amino acid chelates of the present invention are prepared may be broken down into two steps. Step A involves the reaction of one or more amino acids) with a soluble calcium oxide and/or hydroxide in an aqueous solution forming a calcium amino acid chelate or complex product. Step B involves the reaction of a soluble metal sulfate salt with the calcium amino acid chelate or complex product formed in Step A. In one embodiment, the calcium is displaced by the metal forming an electrically neutral amino acid chelate having a ligand to metal molar ratio from 2:1 to 3:1. In another embodiment, the calcium is displaced by the metal forming an amino acid chelate having a ligand to metal molar ratio from 1:1 to 2:1, and having a hydroxide counter ion. In both embodiments, the calcium reacts with the sulfate anion to form an inert and highly insoluble calcium sulfate precipitate.
Certain individual embodiments will be described with more particularity below.
Prepanatiora Of Electrically Neutral Amino Acid Chelates The reactions used to prepare electrically neutral amino acid chelates essentially free of interfering ions and having a ligand to metal molar ratio from about 2:1 to 3:1 are shown below. Formulas 3a and 3b illustrate the production of an amino acid chelate having a 2:1 ligand to metal molar ratio:
Ca(OH)a + 2H(AA) Water] Ca(~)z + 2HZo Ca(AA)z + MS04 watery M(~)2 + CaS04 Formula 3a Ca0 + 2H(AA) Water> Ca(AA)2 + H20 Ca(AA)z + MSO4 Water> M(~)2 + CaS04 Formula 3b In Formulas 3a and 3b above and 4a and 4b below, H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof. H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid. M is a nutritionally relevant metal having a valency of +2 (excluding calcium) such as Cu, Zn, Fe, Co, Mg, and/or Mn.
To illustrate this mechanism further, consider the reactants copper sulfate, calcium oxide, and glycine. First, one mole of calcium oxide is reacted with two moles of glycine. After allowing the calcium and glycine to react, copper sulfate is added. The log of the equilibrium constant at zero ionic strength for the reaction Ca2+ + (Gly)' H Ca(Gly)''-, where (Gly)' represents a glycine anion, is 1.39.
By comparison, for the same reaction with copper rather than calcium, the log of the equilibrium constant is x.56. Though a literature value is not given for the equilibrium constant for the attachment of two glycinate anions to a calcium canon, the principle that copper has stronger affinity for glycine ligands than does calcium is demonstrated by these values.
It is important to note that the reactants, i.e., CaO, H(AA), and MSO4, may be added in any order. For example, all three reactants may be added simultaneously or the amino acid and the soluble metal salt may be added before the calcium oxide or hydroxide. However, the above equation must be balanced so that the final products, M(AA)2, CaS04, and water, are free of interfering ions such that the amino acid chelate is electrically neutral. Therefore, notwithstanding Formula 3a and 3b which illustrates a preferred mechanism, the general formula of the present invention when a 2:1 ligand to metal molar ratio is desired may be represented by Formulas 4a and 4b as follows:
Ca(OH)2+ 2H(AA) + MS04 Wate''> M(AA)2 + CaS04 + 2H20 Formula 4a Ca0 + 2H(AA) + MS04 Water] M(H)z + CaS04 + H20 Formula 4b For purposes of the present invention, multiple metals, amino acids, salts, etc., may be used in the context of the present invention as well. However, metals having a proper valency state should be used, e.g., Cu, Zn, Fe(II), Co, Mg, and/or Mn for amino acid chelates having a ligand to metal molax ratio of about 2:1.
General Formulas 4a and 4b above may be modified to prepare amino acid chelates having a ligand to metal molar ratio of about 3:1 using metals having a valency of +3, e.g., Fe(III), Cr, etc. The general formula of the present invention when a 3:1 ligand to metal molar ratio is desired may be represented by Formulas Sa and Sb as follows:
3Ca(OH)z+ 6H(AA) + M'Z(S04)3 Wa'e~ 2M'(AA)3 + 3CaS0~ + 6H20 Formula Sa 3Ca0 + 6H(AA) + M'2(SO4)3 Water 2M'(AA)3 + 3CaS0ø + 3HZo Formula 5b In Formulas Sa and Sb, H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof. H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present 5 on the amino acid. M' is a nutritionally relevant metal having a valence of +3 such as Fe(III) and/or Cr.
It is important to note that though the compositions and methods of the present invention provide electrically neutral amino acid chelates free of interfering ions, calcium sulfate is always a byproduct. Therefore, the calcium 10 sulfate may be substantially separated out of the compound by methods commonly known in the art while the chelate is still in solution. Alternatively, the calcium sulfate may remain in the compound as a stabilizer or for other purposes.
To cite a specific example of a pure and electrically neutral amino acid chelate having a ligand to metal molar ratio of about 2:1, the following reactions 15 steps may be followed. First, one mole of calcium oxide (Ca0) may be reacted with two moles of glycine to form a reaction product of calcium bisglycinate in water. The problems associated with a hydrogen ion being bound to the amine group are resolved because it has reacted with the oxygen from the Ca0 to form water. To this solution, one mole of copper sulfate (CuS04) is added. This allows for the disassociated copper ions to react with the calcium bisglycinate as the strength of bonding between the copper and the glycinate anion is stronger than the calcium glycinate bond. As such, the calcium is displaced by the copper forming copper bisglycinate. The calcium ions that are displaced in turn react with the sulfate anions (from the CuSOø) forming calcium sulfate which is sparingly soluble and essentially inert.
P~epaYatio~e Of Positively Charged Amiho Acid Chelates Having Hydroxide Counter-Ions The reactions used to prepare amino acid chelates essentially free of interfering ions and having a ligand to metal molar ratio from about 1:1 to 2:1 are shown below. Formulas 6a and 6b illustrate the production of an amino acid chelate having a 1:1 ligand to metal molar ratio:
Ca(OH)2 + H(AA) wateh Ca(AA)*OH' + H20 Ca(AA)+OH' + MS04 "'ate M(AA)+OH' + CaS04 Formula 6a Ca0 + H(AA) Water Ca(AA)+OH' Ca(AA)+OH' + MSO,~ a'ateh M(AA)~OH' + CaSO~
Formula 6b In Formulas 6a, 6b above and Formulas 7a and 7b below, (H)AA is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof. H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid. M is a nutritionally relevant metal having a valency of +2 (excluding calcium) such as Cu, Zn, Fe, Co, Mg, andlor Mn.
To illustrate this mechanism fixrther, consider the reactants copper sulfate, calcium oxide, and glycine. First, one mole of calcium oxide is reacted with one mole of glycine. After allowing the calcium and glycine to react, copper sulfate is added. The log of the equilibrium constant at zero ionic strength for the reaction Ca2+ + (Gly)' ~ Ca(Gly)+, where (Gly)' represents a glycine anion, is 1.39. By comparison, for the same reaction with copper rather than calcium, the log of the equilibrium constant is 8.56. Thus, these values demonstrate that copper has stronger affinity for the glycine ligand than does the calcium.
It is important to note that the added reactants, i.e., Ca0 or Ca(OH)2, H(AA), and MS04, may be added in any order. For example, all three reactants may be added simultaneously or the amino acid and the soluble metal sulfate salt may be added before the calcium oxide or hydroxide. However, the above equation must be balanced to account for all of the potential interfering ions so that the final product (which includes M(AA)+OH' + CaS04) is free of interfering ions. Therefore, notwithstanding Formula 6a and 6b which illustrates the above mechanism, the general formula of the present invention when a 1:1 ligand to metal molar ratio is desired may be represented by Formulas 7a and 7b below:
Ca(OH)2 + H(AA) + MS04 Water] M(~)+OH' + CaS04 + H20 Formula 7a Ca0 + H(AA) + MS04 Water] M(~)+OH_ + CaSOø
Formula 7b For purposes of the present invention, multiple soluble metal sulfate salts, amino acids, etc., may also be used. However, metals with proper oxidation states or valency should be used, e.g., Cu, Zn, Fe(II), Co, Mg, and/or Mn when ~ producing amino acid chelates having a ligand to metal molar ratio of about 1:1.
General Formulas 7a and 7b above may be modified to prepare amino acid chelates having a ligand to metal molar ratio of about 2:1 using nutritionally relevant metals having a valency of +3, e.g., Fe(III), Cr, etc. The general formula of the present invention when a 2:1 ligand to metal molar ratio is desired may be represented by Formulas 8a and 8b below:
3Ca(OH)2+ 4H(AA) + M'2(S04)3 Water 2[M'(AA)2+OH'~~+ 3CaS04 + 4H20 Formula 8a 3Ca,0 + 4H(AA) + M'2(SO4)3 Water 2[M'(AA)2+OH'] + 3CaS04 + H20 Formula 8b In Formulas 8a and 8b, H(AA) is an amino acid selected from the group consisting of naturally occurring amino acids and combinations thereof; H, when disassociated from AA, is a hydrogen ion donor from the carboxyl group present on the amino acid. M' is a nutritionally relevant metal having a valence of +3 such as Fe(III) and/or Cr.
EXAMPLES
The following examples illustrate methods of preparing amino acid chelates that are essentially free of interfering ions. These examples should not be considered as limitations of the present invention, but should merely teach how to make the best known amino acid chelates based upon current experimental data.
Each of the composition examples described herein provide an amount of chalets product produced in solution. However, often, the step of drying, i.e., removing moisture, from a chalets solution may be preferred. Additionally, prior to drying, calcium sulfate (terra alba) may be substantially removed by separation techniques known by those skilled in the art if desired.
P>"eparatiort Of Electrically Neutral Amino Acid Chelates Example 1 - Preparation of copper glycine amino acid chalets Into about 923 grams of water was dissolved 150.14 grams of glycine.
Next, 57.25 grams of calcium oxide, which was about 70% calcium by weight, was added. The solution was continually stirred until all of the calcium oxide was dissolved. This took about 15 minutes. No heat was applied for this particular reaction, though heat could optionally be used in this or other examples. The resulting reaction formed a calcium bisglycinate chalets or complex and water, i. e., the hydrogen ions were removed from the glycine and the oxygen was removed from the calcium oxide.
Next, 254.18 grams of copper sulfate hydrate containing 25% copper by weight was added to the calcium chalets solution. Again, the solution was constantly stirred while the copper sulfate was dissolved. As the copper sulfate went into solution, a white precipitate of calcium sulfate formed. Upon completion of the reaction, about 214 grams of a copper glycine chelate having a ligand to metal molar ratio of 2:1 was formed.
Example 2 - Preparation of zinc glycine amino acid chelate S About 250 grams of glycine was dissolved into 937.8 grams of water.
Once the glycine was significantly dissolved, about 95 grams of calcium oxide was added. The solution was continually stirred for about 15 minutes until all of the calcium was dissolved. The resulting reaction formed a calcium bisglycinate chelate or complex and water.
Next, 299.97 grams of zinc sulfate hydrate containing 35% zinc by weight was added to the calcium chelate solution. Upon constant stirring, the zinc sulfate went into solution and a white precipitate of calcium sulfate formed. About grams of a zinc glycine chelate having a ligand to metal molar ratio of about 2:1 was formed. .
Example 3 - Preparation of manganese glycine amino acid chelate In about 1000 grams of water was dissolved 203.27 grams of glycine and 76.38 grams of calcium oxide. The solution was continually stirred until all of the calcium oxide was dissolved. This took about 15 minutes. No heat was applied for this particular reaction. A calcium bisglycinate chelate or complex aqueous solution was formed.
To the calcium bisglycinate chelate solution was added 272.38 grams of manganese sulfate hydrate containing 27% manganese by weight. Again, the solution was constantly stirred while the manganese sulfate was significantly dissolved. As the manganese sulfate went into solution, a white precipitate of calcium sulfate formed. About 277 grams of a manganese bisglycinate chelate was formed.
Exam~Ie 4 - Preparation of mahgaytese glycihe amiyao acid chelate The procedure of Example 3 may be followed using 100.82 grams of calcium hydroxide instead of 76.38 grams calcium oxide with similar results, i.e., about 277 grams of a manganese bisglycinate is formed, though more water is 5 formed in the reaction.
Example 5 - Preparation of magnesium glycihe amino acid chelate Into about 1500 graxes of water was dissolved 155.63 grams of glycine.
Next, 58.97 grams of calcium oxide, which was 70% calcium by weight, was also 10 added. The solution was continually stirred until all of the calcium oxide was essentially completely dissolved. Again, no heat was applied to the reaction.
A
calcium bisglycinate chelate or complex solution containing excess water was formed.
Next, 572.02 grams of magnesium sulfate hydrate containing 9.86%
15 magnesium by weight was added to the calcium chelate solution. The solution was stirred while the magnesium sulfate dissolved and a white precipitate of calcium sulfate formed. About 211 grams of a magnesium glycinate was formed having a 1:1 ligand to metal molar ratio.
20 Example 6 - Preparation of ferrous glycihe amino acid chelate Into about 1300 grams of water was dissolved 210.72 grams of glycine and 79.86 grams of calcium oxide. The solution was stirred until all of the calcium oxide appeared to be fully dissolved, i.e., about 15 minutes. The resulting reaction formed a calcium bisglycinate chelate or complex solution.
To the calcium bisglycinate chelate or complex solution was added 38I .55 grams of ferrous sulfate hydrate containing 20% ferrous iron by weight. Again, the solution was constantly stirred while the ferrous sulfate dissolved and a white precipitate of calcium sulfate formed. About 287 grams of a ferrous glycine chelate was formed having a ligand to metal molar ratio of about 2:1.
To the calcium bisglycinate chelate or complex solution was added 38I .55 grams of ferrous sulfate hydrate containing 20% ferrous iron by weight. Again, the solution was constantly stirred while the ferrous sulfate dissolved and a white precipitate of calcium sulfate formed. About 287 grams of a ferrous glycine chelate was formed having a ligand to metal molar ratio of about 2:1.
Example 7 - P~eparatio~t of zinc glycihelmethiohihe amino acid chelate About 700 grains of water used to dissolve 86.5 grams of glycine and 70 grams of DL-methionine. Next, 47 grams of calcium oxide, which was 70%
calcium by weight, was added. The solution was continually stirred until all of the calcium oxide appeared to be dissolved. The reaction formed a calcium bisglycinate chelate or complex solution.
Next, 150 grams of zinc sulfate hydrate containing 35.5% zinc by weight was stirred into the calcium chelate solution wherein a white precipitate of calcium sulfate formed as a by-product. This process produced about 210 grams of a zinc glycine/methionine chelate having a ligand to metal molar ratio of 2:1.
Example 8 - Preparation of copper, zinc, and manganese ami~to acid chelate mixture About 2400 grams of water was used to dissolve 475 grams of glycine.
Next, 175 grains of calcium oxide, which was 70% calcium by weight, was stirred into the aqueous solution. The solution was continually stirred for about 15 minutes until all of the calcium oxide was dissolved and a calcium bisglycinate chelate or complex solution was formed.
To the calcium bisglycinate chelate or complex solution was added about 110 grams of copper sulfate hydrate containing 25% copper by weight, 300 grams of zinc sulfate hydrate containing 35% zinc by weight, and 185 grams of manganese sulfate hydrate containing 29% manganese by weight. Again, the solution was constantly stirred while the copper sulfate, zinc sulfate, and manganese sulfate were all dissolved and calcium sulfate had fully precipitated.
This process produced about 661 grams of amino acid chelates comprised of glycine as the ligand and copper, zinc, and/or manganese as the metal. The ligand to metal molar ratio was generally about 2:1.
calcium by weight, was added. The solution was continually stirred until all of the calcium oxide appeared to be dissolved. The reaction formed a calcium bisglycinate chelate or complex solution.
Next, 150 grams of zinc sulfate hydrate containing 35.5% zinc by weight was stirred into the calcium chelate solution wherein a white precipitate of calcium sulfate formed as a by-product. This process produced about 210 grams of a zinc glycine/methionine chelate having a ligand to metal molar ratio of 2:1.
Example 8 - Preparation of copper, zinc, and manganese ami~to acid chelate mixture About 2400 grams of water was used to dissolve 475 grams of glycine.
Next, 175 grains of calcium oxide, which was 70% calcium by weight, was stirred into the aqueous solution. The solution was continually stirred for about 15 minutes until all of the calcium oxide was dissolved and a calcium bisglycinate chelate or complex solution was formed.
To the calcium bisglycinate chelate or complex solution was added about 110 grams of copper sulfate hydrate containing 25% copper by weight, 300 grams of zinc sulfate hydrate containing 35% zinc by weight, and 185 grams of manganese sulfate hydrate containing 29% manganese by weight. Again, the solution was constantly stirred while the copper sulfate, zinc sulfate, and manganese sulfate were all dissolved and calcium sulfate had fully precipitated.
This process produced about 661 grams of amino acid chelates comprised of glycine as the ligand and copper, zinc, and/or manganese as the metal. The ligand to metal molar ratio was generally about 2:1.
Example 9 - P~epa~atioh of copper, zinc, manganese, and iron amino acid chelate mixture To about 2600 grams of water was stirred 455 grams of glycine and 173 grams of calcium oxide. Once the glycine and calcium oxide had dissolved, a calcium bisglycinate chelate or complex solution was formed.
Next, about 10 grams of copper sulfate hydrate containing 25% Cu by weight, 142 grams of zinc sulfate hydrate containing 35% Zn by weight, 65 grams of manganese sulfate hydrate containing 29% Mn by weight, and 500 grams of iron sulfate hydrate containing 20% Fe by weight were added to the calcium chelate solution. Again, the solution was constantly stirred while the copper sulfate, zinc sulfate, manganese sulfate, and ferrous sulfate were dissolved.
A
calcium sulfate precipitate formed as well as about 626 grams of amino acid chelates comprised of glycine as the ligand and copper, zinc, manganese, and/or iron as the metal. The ligand to metal molar ratio was generally about 2:1.
Example 10 - P~eparatioh of ~ihc glycihe amino acid chelate About 250 grams of glycine, about 95 grams of calcium oxide , and about 300 grams of zinc sulfate(35.5% zinc by weight) were simultaneously dissolved into 937.8 grams of water. Under no added heat, the solution was continually stirred for about 30 minutes. As the zinc sulfate and the calcium oxide went into solution, a white precipitate of calcium sulfate and about 356 grams of a zinc glycine chelate having a ligand to metal molar ratio of 2:1 was formed.
Example 11 - Preparation of ferrous glycihe amino acid chelate To about 1300 grams of water was added about 382 grams of ferrous sulfate containing 20% Fe(II) by weight. The solution was stirred until the ferrous sulfate dissolved. Next, about 211 grams of glycine was stirred into the solution for about 30 minutes. To the aqueous solution was added about 80 grams of calcium oxide. Again the solution was continually stirred until all of the Ca0 was dissolved. As the calcium oxide went into solution, a white precipitate of calcium sulfate as well as about 287 grams of a ferrous glycine chelate having a ligand to metal molar ratio of 2:1 was formed.
Example 12 - Preparation of chromium glycine amino acid chelate About 2252 grams of water was used to dissolve 450.42 grams of glycine and 168.24 grams of calcium oxide into solution. The resulting reaction formed a calcium trisglycinate chelate or complex solution.
Next, 500.18 grams of chromic sulfate hydrate containing 19% chromium by weight was added to the calcium chelate solution. The solution was stirred while the copper sulfate was dissolved and as a white precipitate of calcium sulfate formed. Upon completion of the reaction, about 545 grams of a chromic trisglycinate chelate having a ligand to metal molar ratio of about 3:1 was formed.
Example 13 - Preparation of chromium glycine amino acid chelate The procedure of Example 12 rnay be followed using 222.08 grams of calcium hydroxide instead of 168.24 grams calcium oxide with similar results, i. e., about 545 grams of a chromic trisglycinate is formed.
Preparation Of Positively Charged Amino Acid Chelates Having Hydroxide Counter Ions Example 14 - Preparation of coppers glycine amino acid chelate Into about 1500 graxes of water was dissolved 150.14 grams of glycine.
Next, 114.51 grams of calcium oxide, which was 70% calcium by weight, was added. The solution was continually stirred until aII of the calcium oxide was dissolved. This took about 15 minutes. No heat was applied for this particular reaction, though heat could optionally be used. The resulting reaction formed a calcium glycinate chelate or complex.
Next, 508.2 grams of copper sulfate pentahydrate containing 25% Cu by weight was added to the calcium chelate solution. Again, the solution was constantly stirred while the copper sulfate was dissolved. As the copper sulfate went into solution, a white precipitate of calcium sulfate formed. About 277 grams of a copper glycine amino acid chelate having a ligand to metal molar ratio of about l: l was produced.
S
Example 1 S - Prepa~atioy~. of copper alanihe amino acid chelate A reaction mixture was prepared comprising 33.96 grams of calcium oxide, 108.09 grams of alanine, and 700 grams of water. The mixture was stirred for 15 minutes. Next, 301.83 grams of copper sulfate pentahydrate was added to the reaction mixture. As the solution was further stirred, a white precipitate of calcium sulfate formed. Once the reaction was complete, 205.1 S grams of a copper alanine amino acid chelate having a ligand to metal molar ratio of about 1:1 remained in solution.
1 S Example 16 - Preparation of iroya se~ihe amino acid chelate A solution was prepared containing 58.23 grams of calcium oxide, 218.18 grams of serine, and 700 grams of water. The reaction mixture was stirred for about 1 S minutes while the reaction advanced. Next, 261.89 grams of ferrous sulfate pentahydrate was added to the reaction mixture and stirred for about I
S
minutes. In addition to the calcium sulfate precipitate (terra alba) produced, 367.35 grams of an iron serine amino acid chelate having a ligand to metal molar ratio of about 1:1 was produced.
Example 17 - Preparation of copper lysine amino acid chelate 2S A reaction mixture comprised of 5.58 grams of calcium oxide, 32.66 grams of lysine monohydrate, and 700 grams of water was prepared and allowed to react while stirring for 30 minutes. To the liquid reaction mixture, 49.94 grams of copper sulfate pentahydrate was added and stirred until the reaction appeared complete. A white precipitate of calcium sulfate formed during the reaction.
The reactants produced 45.14 grams of a copper lysine amino acid chelate having a Iigand to metal molar ratio of about I : I .
Example 18 - Preparation of zinc cysteinelglycine amino acid chelate 5 A solution comprising 56.08 grams of calcium oxide, 60.58 grams of cysteine, 37.53 grams of glycine, and 700 graxes of water was prepared and allowed to react for 30 minutes while being stirred. Next, 161.44 grams of zinc sulfate was added and stirred until the zinc sulfate dissolved. In addition to the formation of the terra alba, 179.49 grams of a zinc cysteine/glycine amino acid 10 chelate having a ligand to metal molar ratio of about 1:1 was formed.
Example 19 - Preparation of chromium glycine amino acid chelate In 750 grams of water, 84.12 grams of calcium oxide was reacted with 150.14 grams of glycine for 30 minutes to form a liquid reaction mixture.
Next, 15 250.09 grams of chromium sulfate hexahydrate was added to the reaction mixture and stirred. About 219 grams of a chromium glycine amino acid chelate having a ligand to metal molar ratio of about 2:1 was produced in addition to the terra alba formed.
20 Example 20 - Preparation of copper series amino acid chelate A reaction mixture comprised of 74.1 grams of calcium hydroxide, 105.1 grams of series, and 700 grams of water was prepared and allowed to react for minutes while stirring. Next, 249.6 grams of copper sulfate pentahydrate was stirred into the solution and a white precipitate of calcium sulfate formed.
Once 25 the reaction was complete, a total of 184.7 grams of a copper series amino acid chelate having a ligand to metal molar ratio of about 1:1 was produced.
Example 21 - Preparatiort of chromium glycine amino acid chelate In 750 grams of water, 111.14 grains of calcium hydroxide was reacted with 150.14 grams of glycine for 30 minutes. Next, 250.09 grams of chromium sulfate was added and stirred until the calcium sulfate ceased significant precipitation. About 219 grams of a chromium amino acid chelate having a ligand to metal molar ratio of about 2:1 was produced.
Example 22 - Preparation of copper glycihe amino acid chelate To about 1500 grams of water was dissolved 150.14 grams of glycine, 114.51 grams of calcium oxide, and 508.2 grams of copper sulfate pentahydrate.
The solution was constantly stirred while the copper sulfate and the calcium oxide was dissolved. As the copper sulfate went into solution, a white precipitate of calcium sulfate formed. About 277 grams of a copper glycine amino acid chelate having a ligand to metal molar ratio of about 1:1 was produced.
Example 23 - Preparation of copper lysiyae amino acid chelate To about 700 grams of water was added about 49.94 grams of copper sulfate pentahydrate. The solution was stirred until the copper sulfate dissolved.
Next, 32.66 grams of lysine was stirred into the solution for about 30 minutes. To the aqueous solution was added 5.58 grams of calcium oxide. Again the solution was continually stirred until all of the calcium oxide was dissolved. As the calcium oxide went into solution, a white precipitate of calcium sulfate formed.
Additionally, there was recovered 45.14 grams of a copper lysine amino acid chelate having a ligand to metal molar ratio of about 1:1.
Physical Property Comparison Betweeya Ara Amino Acid Chelate Arid Aya Amino Acid Chelates In The Presence Of Terra Alba Example 24 - Comparisofa A 10:1 mixture of copper bisglycinate to terra alba (CaS04) [Sample 1]
was prepared and shaken together in a plastic bag. Next, a pure copper glycinate without the presence of terra alba [Sample 2] was also prepared and shaken in a plastic bag. With regard to Sample 1, no particulates stuck to the walls of the bag. Conversely, with Sample 2, a blue haze of product stuck the walls of the bag. This demonstrated that Sample 1 was less electrostatic.
Sample 1 was further compared to Sample 2 by rubbing a portion of each between the thumb and finger. Sample 2 quickly balled up with moisture from the thumb and finger as well as from the surrounding air. Conversely, Sample 1 did not ball up. This demonstrated that Sample 1 was less hygroscopic.
The particle size found in Sample l and Sample 2 was~about 70 mesh.
Thus, the presence of terra alba did not significantly change the particle size.
Finally, Sample 2 was added to a stimulated gastric solution which caused the product to change color. Sample 1 was similarly added to a stimulated gastric solution. However, no color change was observed demonstrating the stabilizing effect of terra alba on an amino acid chelate in an acid environment.
While the invention has been described with reference to certain preferred embodiments, those skilled in the art will appreciate that various modifications, changes, omissions, and substitutions can be made without departing from the spirit of the invention. It is intended, therefore, that the invention be limited only by the scope of the following claims.
Next, about 10 grams of copper sulfate hydrate containing 25% Cu by weight, 142 grams of zinc sulfate hydrate containing 35% Zn by weight, 65 grams of manganese sulfate hydrate containing 29% Mn by weight, and 500 grams of iron sulfate hydrate containing 20% Fe by weight were added to the calcium chelate solution. Again, the solution was constantly stirred while the copper sulfate, zinc sulfate, manganese sulfate, and ferrous sulfate were dissolved.
A
calcium sulfate precipitate formed as well as about 626 grams of amino acid chelates comprised of glycine as the ligand and copper, zinc, manganese, and/or iron as the metal. The ligand to metal molar ratio was generally about 2:1.
Example 10 - P~eparatioh of ~ihc glycihe amino acid chelate About 250 grams of glycine, about 95 grams of calcium oxide , and about 300 grams of zinc sulfate(35.5% zinc by weight) were simultaneously dissolved into 937.8 grams of water. Under no added heat, the solution was continually stirred for about 30 minutes. As the zinc sulfate and the calcium oxide went into solution, a white precipitate of calcium sulfate and about 356 grams of a zinc glycine chelate having a ligand to metal molar ratio of 2:1 was formed.
Example 11 - Preparation of ferrous glycihe amino acid chelate To about 1300 grams of water was added about 382 grams of ferrous sulfate containing 20% Fe(II) by weight. The solution was stirred until the ferrous sulfate dissolved. Next, about 211 grams of glycine was stirred into the solution for about 30 minutes. To the aqueous solution was added about 80 grams of calcium oxide. Again the solution was continually stirred until all of the Ca0 was dissolved. As the calcium oxide went into solution, a white precipitate of calcium sulfate as well as about 287 grams of a ferrous glycine chelate having a ligand to metal molar ratio of 2:1 was formed.
Example 12 - Preparation of chromium glycine amino acid chelate About 2252 grams of water was used to dissolve 450.42 grams of glycine and 168.24 grams of calcium oxide into solution. The resulting reaction formed a calcium trisglycinate chelate or complex solution.
Next, 500.18 grams of chromic sulfate hydrate containing 19% chromium by weight was added to the calcium chelate solution. The solution was stirred while the copper sulfate was dissolved and as a white precipitate of calcium sulfate formed. Upon completion of the reaction, about 545 grams of a chromic trisglycinate chelate having a ligand to metal molar ratio of about 3:1 was formed.
Example 13 - Preparation of chromium glycine amino acid chelate The procedure of Example 12 rnay be followed using 222.08 grams of calcium hydroxide instead of 168.24 grams calcium oxide with similar results, i. e., about 545 grams of a chromic trisglycinate is formed.
Preparation Of Positively Charged Amino Acid Chelates Having Hydroxide Counter Ions Example 14 - Preparation of coppers glycine amino acid chelate Into about 1500 graxes of water was dissolved 150.14 grams of glycine.
Next, 114.51 grams of calcium oxide, which was 70% calcium by weight, was added. The solution was continually stirred until aII of the calcium oxide was dissolved. This took about 15 minutes. No heat was applied for this particular reaction, though heat could optionally be used. The resulting reaction formed a calcium glycinate chelate or complex.
Next, 508.2 grams of copper sulfate pentahydrate containing 25% Cu by weight was added to the calcium chelate solution. Again, the solution was constantly stirred while the copper sulfate was dissolved. As the copper sulfate went into solution, a white precipitate of calcium sulfate formed. About 277 grams of a copper glycine amino acid chelate having a ligand to metal molar ratio of about l: l was produced.
S
Example 1 S - Prepa~atioy~. of copper alanihe amino acid chelate A reaction mixture was prepared comprising 33.96 grams of calcium oxide, 108.09 grams of alanine, and 700 grams of water. The mixture was stirred for 15 minutes. Next, 301.83 grams of copper sulfate pentahydrate was added to the reaction mixture. As the solution was further stirred, a white precipitate of calcium sulfate formed. Once the reaction was complete, 205.1 S grams of a copper alanine amino acid chelate having a ligand to metal molar ratio of about 1:1 remained in solution.
1 S Example 16 - Preparation of iroya se~ihe amino acid chelate A solution was prepared containing 58.23 grams of calcium oxide, 218.18 grams of serine, and 700 grams of water. The reaction mixture was stirred for about 1 S minutes while the reaction advanced. Next, 261.89 grams of ferrous sulfate pentahydrate was added to the reaction mixture and stirred for about I
S
minutes. In addition to the calcium sulfate precipitate (terra alba) produced, 367.35 grams of an iron serine amino acid chelate having a ligand to metal molar ratio of about 1:1 was produced.
Example 17 - Preparation of copper lysine amino acid chelate 2S A reaction mixture comprised of 5.58 grams of calcium oxide, 32.66 grams of lysine monohydrate, and 700 grams of water was prepared and allowed to react while stirring for 30 minutes. To the liquid reaction mixture, 49.94 grams of copper sulfate pentahydrate was added and stirred until the reaction appeared complete. A white precipitate of calcium sulfate formed during the reaction.
The reactants produced 45.14 grams of a copper lysine amino acid chelate having a Iigand to metal molar ratio of about I : I .
Example 18 - Preparation of zinc cysteinelglycine amino acid chelate 5 A solution comprising 56.08 grams of calcium oxide, 60.58 grams of cysteine, 37.53 grams of glycine, and 700 graxes of water was prepared and allowed to react for 30 minutes while being stirred. Next, 161.44 grams of zinc sulfate was added and stirred until the zinc sulfate dissolved. In addition to the formation of the terra alba, 179.49 grams of a zinc cysteine/glycine amino acid 10 chelate having a ligand to metal molar ratio of about 1:1 was formed.
Example 19 - Preparation of chromium glycine amino acid chelate In 750 grams of water, 84.12 grams of calcium oxide was reacted with 150.14 grams of glycine for 30 minutes to form a liquid reaction mixture.
Next, 15 250.09 grams of chromium sulfate hexahydrate was added to the reaction mixture and stirred. About 219 grams of a chromium glycine amino acid chelate having a ligand to metal molar ratio of about 2:1 was produced in addition to the terra alba formed.
20 Example 20 - Preparation of copper series amino acid chelate A reaction mixture comprised of 74.1 grams of calcium hydroxide, 105.1 grams of series, and 700 grams of water was prepared and allowed to react for minutes while stirring. Next, 249.6 grams of copper sulfate pentahydrate was stirred into the solution and a white precipitate of calcium sulfate formed.
Once 25 the reaction was complete, a total of 184.7 grams of a copper series amino acid chelate having a ligand to metal molar ratio of about 1:1 was produced.
Example 21 - Preparatiort of chromium glycine amino acid chelate In 750 grams of water, 111.14 grains of calcium hydroxide was reacted with 150.14 grams of glycine for 30 minutes. Next, 250.09 grams of chromium sulfate was added and stirred until the calcium sulfate ceased significant precipitation. About 219 grams of a chromium amino acid chelate having a ligand to metal molar ratio of about 2:1 was produced.
Example 22 - Preparation of copper glycihe amino acid chelate To about 1500 grams of water was dissolved 150.14 grams of glycine, 114.51 grams of calcium oxide, and 508.2 grams of copper sulfate pentahydrate.
The solution was constantly stirred while the copper sulfate and the calcium oxide was dissolved. As the copper sulfate went into solution, a white precipitate of calcium sulfate formed. About 277 grams of a copper glycine amino acid chelate having a ligand to metal molar ratio of about 1:1 was produced.
Example 23 - Preparation of copper lysiyae amino acid chelate To about 700 grams of water was added about 49.94 grams of copper sulfate pentahydrate. The solution was stirred until the copper sulfate dissolved.
Next, 32.66 grams of lysine was stirred into the solution for about 30 minutes. To the aqueous solution was added 5.58 grams of calcium oxide. Again the solution was continually stirred until all of the calcium oxide was dissolved. As the calcium oxide went into solution, a white precipitate of calcium sulfate formed.
Additionally, there was recovered 45.14 grams of a copper lysine amino acid chelate having a ligand to metal molar ratio of about 1:1.
Physical Property Comparison Betweeya Ara Amino Acid Chelate Arid Aya Amino Acid Chelates In The Presence Of Terra Alba Example 24 - Comparisofa A 10:1 mixture of copper bisglycinate to terra alba (CaS04) [Sample 1]
was prepared and shaken together in a plastic bag. Next, a pure copper glycinate without the presence of terra alba [Sample 2] was also prepared and shaken in a plastic bag. With regard to Sample 1, no particulates stuck to the walls of the bag. Conversely, with Sample 2, a blue haze of product stuck the walls of the bag. This demonstrated that Sample 1 was less electrostatic.
Sample 1 was further compared to Sample 2 by rubbing a portion of each between the thumb and finger. Sample 2 quickly balled up with moisture from the thumb and finger as well as from the surrounding air. Conversely, Sample 1 did not ball up. This demonstrated that Sample 1 was less hygroscopic.
The particle size found in Sample l and Sample 2 was~about 70 mesh.
Thus, the presence of terra alba did not significantly change the particle size.
Finally, Sample 2 was added to a stimulated gastric solution which caused the product to change color. Sample 1 was similarly added to a stimulated gastric solution. However, no color change was observed demonstrating the stabilizing effect of terra alba on an amino acid chelate in an acid environment.
While the invention has been described with reference to certain preferred embodiments, those skilled in the art will appreciate that various modifications, changes, omissions, and substitutions can be made without departing from the spirit of the invention. It is intended, therefore, that the invention be limited only by the scope of the following claims.
Claims (28)
1. A method of preparing electrically neutral amino acid chelates free of interfering ions, comprising:
reacting in an aqueous solution, a) a calcium oxide or hydroxide, b) an amino acid, and c) a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the reactants present in solution to react forming an electrically neutral metal amino acid chelate, and calcium sulfate, and wherein said metal amino acid chelate has a ligand to metal molar ratio from 2:1 to 3:1.
reacting in an aqueous solution, a) a calcium oxide or hydroxide, b) an amino acid, and c) a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the reactants present in solution to react forming an electrically neutral metal amino acid chelate, and calcium sulfate, and wherein said metal amino acid chelate has a ligand to metal molar ratio from 2:1 to 3:1.
2. A method of preparing amino acid chelates free of interfering ions, comprising:
reacting in an aqueous solution, a) a calcium oxide or hydroxide, b) an amino acid, and c) a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the reactants present in solution to react forming a positively charged metal amino acid chelate having a hydroxide counter-ion, and calcium sulfate, and wherein said metal amino acid chelate has a ligand to metal molar ratio from about 1:1 to 2:1.
reacting in an aqueous solution, a) a calcium oxide or hydroxide, b) an amino acid, and c) a soluble metal sulfate salt at a ratio sufficient to allow substantially all of the reactants present in solution to react forming a positively charged metal amino acid chelate having a hydroxide counter-ion, and calcium sulfate, and wherein said metal amino acid chelate has a ligand to metal molar ratio from about 1:1 to 2:1.
3. A method as in claim 1 wherein the metal is divalent and the ligand to metal molar ratio is about 2:1.
4. A method as in claim 1 wherein the metal is trivalent and the ligand to metal molar ratio is about 3:1.
5. A method as in claim 2 wherein the metal is divalent and the ligand to metal molar ratio is about 1:1.
6. A method as in.claim 2 wherein the metal is trivalent and the ligand to metal molar ratio is about 2:1.
7. A method as in claim 1 or 2 wherein said amino acid is selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, cystine, glutamine, glutamic acid, glycine, histidine, hydroxyproline, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and combinations thereof, and dipeptides, tripeptides, and tetrapeptides formed by any combination of said amino acids thereof.
8. A method as in claim 1 or 2 wherein said metal is a divalent or trivalent cation selected from the group consisting of Cu, Zn, Fe, Cr, Co, Mg, Mn, and combinations thereof.
9. A method as in claim 1 or 2 wherein said soluble metal sulfate salt is a member selected from the group consisting CuSO4, ZnSO4, FeSO4, CoSO4, MnSO4, MgSO4, Fe2(SO4)3, Cr2(SO4)3, and combinations thereof.
10. A method as in claim 1 wherein said amino acid is glycine and said metal amino acid chelate is selected from the group consisting of copper bisglycinate, zinc bisglycinate, iron bisglycinate, iron trisglycinate, chromium trisglycinate, cobalt bisglycinate, magnesium bisglycinate, manganese bisglycinate, and combinations thereof.
11. A method as in claim 1 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 2:1 and the reaction is further defined by:
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
12. A method as in claim 1 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 2:1 and the reaction is further defined by:
CaO + 2H(AA) + MSO4 ~ M(AA)2 + CaSO4 + H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
CaO + 2H(AA) + MSO4 ~ M(AA)2 + CaSO4 + H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
13. A method as in claim 1 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 3: l and the reaction is further defined by:
3Ca(OH)2+ 6H(AA) + M'2(SO4)3 ~ 2M'(AA)3 + 3CaSO4 + 6H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
3Ca(OH)2+ 6H(AA) + M'2(SO4)3 ~ 2M'(AA)3 + 3CaSO4 + 6H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
14. A method as in claim 1 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 3:1 and the reaction is further defined by:
3CaO + 6H(AA) + M'2(SO4)3 ~ 2M'(AA)3 + 3CaSO4 + 3H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
3CaO + 6H(AA) + M'2(SO4)3 ~ 2M'(AA)3 + 3CaSO4 + 3H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
15. A method as in claim 2 wherein said amino acid is glycine and said metal amino acid chelate is selected from the group consisting of copper glycinate, zinc glycinate, iron glycinate, iron bisglycinate, chromium bisglycinate, cobalt glycinate, magnesium glycinate, manganese glycinate, and combinations thereof.
16. A method as in claim 2 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 1:1 and the reaction is further defined by:
Ca(OH)2+ H(AA) + MSO4 ~ M(AA)+OH + CaSo4 + H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
Ca(OH)2+ H(AA) + MSO4 ~ M(AA)+OH + CaSo4 + H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
17. A method as in claim 2 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 1:1 and the reaction is further defined by:
CaO + H(AA) + MSO4 ~ M(AA)+OH' + CaSO4 where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogenion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
CaO + H(AA) + MSO4 ~ M(AA)+OH' + CaSO4 where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogenion donor from the carboxyl group present on the amino acid; and M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
18. A method as in claim 2 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 2:1 and the reaction is further defined by:
3Ca(OH)2+ 4H(AA) + M'2(SO4)3 ~ 2[M'(AA)2+OH] + 3CaSO4 + 4H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
3Ca(OH)2+ 4H(AA) + M'2(SO4)3 ~ 2[M'(AA)2+OH] + 3CaSO4 + 4H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
19. A method as in claim 2 wherein said metal amino acid chelate has a ligand to metal molar ratio of about 2:1 and the reaction is further defined by:
3CaO + 4H(AA) + M'2(SO4)3 ~ 2[M'(AA)2+OH-] + 3CaSO4 + H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
3CaO + 4H(AA) + M'2(SO4)3 ~ 2[M'(AA)2+OH-] + 3CaSO4 + H2O
where H(AA) is one or more naturally occurring amino acids; H when disassociated from AA is a hydrogen ion donor from the carboxyl group present on the amino acid; and M' is selected from the group consisting of Fe, Cr, and combinations thereof.
20. A method as in claim 1 or 2 wherein said calcium sulfate is substantially separated out.
21. A method as in claim 1 or 2 wherein said calcium sulfate is not separated out.
22. A method as in claim 1 or 2 further comprising a subsequent step of drying the metal amino acid chelate and the calcium sulfate.
23. An amino acid chelate free of interfering ions prepared according to any one of claims 1-6 and 10-19.
24. An amino acid chelate as in claim 23 wherein the amino acid chelate is substantially dried to form a particulate product.
25. An amino acid chelate having the formula:
M(AA)+OH-where AA is an anion of one or more naturally occurring amino acids, and M is a divalent metal ion.
M(AA)+OH-where AA is an anion of one or more naturally occurring amino acids, and M is a divalent metal ion.
26. An amino acid chelate as in claim 25 wherein M is selected from the group consisting of Cu, Zn, Fe, Co, Mg, Mn, and combinations thereof.
27. An amino acid chelate having the formula:
M'(AA)2+OH-where AA is an anion of one or more naturally occurring amino acids, and M' is a trivalent metal ion.
M'(AA)2+OH-where AA is an anion of one or more naturally occurring amino acids, and M' is a trivalent metal ion.
28. An amino acid chelate as in claim 27 wherein M' is selected from the group consisting of Fe, Cr, and combinations thereof.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/686,684 US6407138B1 (en) | 2000-10-11 | 2000-10-11 | Composition and method for preparing electrically neutral amino acid chelates free of interfering ions |
| US09/686,046 US6458981B1 (en) | 2000-10-11 | 2000-10-11 | Composition and method for preparing amino acid chelate hydroxides free of interfering ions |
| US09/686,046 | 2000-10-11 | ||
| US09/686,684 | 2000-10-11 | ||
| PCT/US2001/031758 WO2002030948A2 (en) | 2000-10-11 | 2001-10-10 | A composition and method for preparing amino acid chelates free of interfering ions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2425473A1 true CA2425473A1 (en) | 2002-04-18 |
Family
ID=27103727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002425473A Abandoned CA2425473A1 (en) | 2000-10-11 | 2001-10-10 | A composition and method for preparing amino acid chelates free of interfering ions |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1325012A4 (en) |
| AU (1) | AU2002213106A1 (en) |
| CA (1) | CA2425473A1 (en) |
| WO (1) | WO2002030948A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4210037B2 (en) * | 2001-02-16 | 2009-01-14 | 村樫石灰工業株式会社 | Antibacterial composition |
| US7994217B2 (en) | 2002-05-02 | 2011-08-09 | Xanodyne Pharmaceuticals, Inc. | Prenatal multivitamin/multimineral supplement |
| CN101062913B (en) * | 2007-06-05 | 2013-01-23 | 重庆大学 | Preparation method of hydroxyproline-zinc chelate complex |
| CN103467331B (en) * | 2013-09-26 | 2015-01-21 | 山东祥维斯生物科技有限公司 | Iron glycine chelate crystal growth method |
| CN106858610B (en) * | 2017-03-01 | 2018-05-22 | 岳智广 | The preparation method of a kind of amino acid chelated calcium and including the chelated calcium calcium-supplementing preparation |
| KR102058676B1 (en) * | 2017-07-14 | 2019-12-24 | 씨제이제일제당 주식회사 | Methionine-Metal Chelate and Manufacturing Method thereof |
| KR102068016B1 (en) * | 2017-07-14 | 2020-01-21 | 씨제이제일제당 주식회사 | Methionine-Metal Chelate and Manufacturing Method thereof |
| ES2955166T3 (en) * | 2018-12-18 | 2023-11-29 | Phytobiotics Futterzusatzstoffe Gmbh | Production of a lysinate compound from an aqueous lysine solution |
| CN110330439A (en) * | 2019-07-12 | 2019-10-15 | 辽阳华路催化技术研发有限公司 | A kind of zinc-glycine complex and preparation method thereof not introducing foreign ion |
| CN110734331B (en) * | 2019-10-28 | 2022-03-11 | 内蒙古阜丰生物科技有限公司 | Compound fertilizer prepared by utilizing glutamic acid fermentation waste |
| CN111116438B (en) * | 2019-12-25 | 2022-05-20 | 长沙兴嘉生物工程股份有限公司 | Preparation method and application of manganese cystine |
| CN121181928B (en) * | 2025-11-21 | 2026-03-06 | 广东药科大学 | Bimetallic complex with whitening and anti-aging effects and preparation method and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3950372A (en) * | 1974-07-03 | 1976-04-13 | Zinpro Corporation | 1:1 Manganese alpha amino acid complexes |
| US4425280A (en) * | 1981-03-30 | 1984-01-10 | Ferro Corporation | Metal amino acids |
| US4830716B1 (en) * | 1986-07-03 | 1999-12-07 | Albion Int | Preparation of pharmaceutical grade amino acid chelates |
| US5292729A (en) * | 1992-08-14 | 1994-03-08 | Albion International, Inc. | II-bond aromatic vitamin chelates |
| US5698724A (en) * | 1996-04-30 | 1997-12-16 | Zinpro Corporation | Amino acid metal complexes using hydrolyzed protein as the amino acid source and methods re same |
-
2001
- 2001-10-10 WO PCT/US2001/031758 patent/WO2002030948A2/en not_active Ceased
- 2001-10-10 CA CA002425473A patent/CA2425473A1/en not_active Abandoned
- 2001-10-10 AU AU2002213106A patent/AU2002213106A1/en not_active Abandoned
- 2001-10-10 EP EP01981466A patent/EP1325012A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002030948A3 (en) | 2002-07-18 |
| WO2002030948A2 (en) | 2002-04-18 |
| EP1325012A2 (en) | 2003-07-09 |
| EP1325012A4 (en) | 2005-08-10 |
| AU2002213106A1 (en) | 2002-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6458981B1 (en) | Composition and method for preparing amino acid chelate hydroxides free of interfering ions | |
| US6407138B1 (en) | Composition and method for preparing electrically neutral amino acid chelates free of interfering ions | |
| US6710079B1 (en) | Composition and method for preparing amino acid chelates and complexes free of interfering complex ions | |
| JP2547026B2 (en) | Method for producing pharmaceutical grade amino acid chelate | |
| AU689312B2 (en) | Amino acid chelates having improved palatability | |
| EP1274419B1 (en) | Zinc amino acid chelates having ligands comprised of glycine and a sulfur-containing amino acid | |
| US6518240B1 (en) | Composition and method for preparing amino acid chelates and complexes | |
| US6426424B1 (en) | Composition and method for preparing granular amino acid chelates and complexes | |
| CA2142358C (en) | .pi.-bond aromatic vitamin chelates | |
| CA2457584C (en) | Enhancing solubility of iron amino acid chelates and iron proteinates | |
| CA2425473A1 (en) | A composition and method for preparing amino acid chelates free of interfering ions | |
| WO2002030947A2 (en) | Compositions and methods of preparing amino acid chelates and complexes | |
| JP2006503092A (en) | Metal complex of α-aminodicarboxylic acid | |
| US20090182044A1 (en) | Nitrate amino acid chelates | |
| CA2197883C (en) | 1,2-disubstituted aromatic chelates | |
| KR100481326B1 (en) | Producing process for organic chelate | |
| WO2008034238A1 (en) | Methods for producing pure amino acid chelate complexes, and uses thereof | |
| US7341708B1 (en) | Methods for producing pure amino acid chelate complexes, and uses thereof | |
| BR102015029710A2 (en) | chelated minerals with soy amino acids | |
| JP2002047266A (en) | Composition containing methionine / transition metal complex and amino acid | |
| RU2764579C1 (en) | Method for producing a composition containing at least one compound of a metal with an amino acid, and composition produced by this method | |
| WO2004082592A2 (en) | Metal amino acid chelates having nutritionally relevant anion radical (s) | |
| JP5113315B2 (en) | Agricultural crop mineral supplement and method for producing the same | |
| KR100581743B1 (en) | Metal complexes of 2-hydroxy-4-methylthiobutanoic acid for use as animal feed | |
| JP4252882B2 (en) | Method for producing metal organic acid chelate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |